Stem Cells International

Stem Cells International / 2019 / Article
Special Issue

Engineering Cell Systems

View this Special Issue

Review Article | Open Access

Volume 2019 |Article ID 8203950 | 20 pages |

Unchain My Heart: Integrins at the Basis of iPSC Cardiomyocyte Differentiation

Academic Editor: Tiago Fernandes
Received31 Oct 2018
Revised20 Dec 2018
Accepted10 Jan 2019
Published13 Feb 2019


The cellular response to the extracellular matrix (ECM) microenvironment mediated by integrin adhesion is of fundamental importance, in both developmental and pathological processes. In particular, mechanotransduction is of growing importance in groundbreaking cellular models such as induced pluripotent stem cells (iPSC), since this process may strongly influence cell fate and, thus, augment the precision of differentiation into specific cell types, e.g., cardiomyocytes. The decryption of the cellular machinery starting from ECM sensing to iPSC differentiation calls for new in vitro methods. Conveniently, engineered biomaterials activating controlled integrin-mediated responses through chemical, physical, and geometrical designs are key to resolving this issue and could foster clinical translation of optimized iPSC-based technology. This review introduces the main integrin-dependent mechanisms and signalling pathways involved in mechanotransduction. Special consideration is given to the integrin-iPSC linkage signalling chain in the cardiovascular field, focusing on biomaterial-based in vitro models to evaluate the relevance of this process in iPSC differentiation into cardiomyocytes.

1. Introduction

The integrin protein family is a large group of transmembrane receptors, particularly involved in cell-extracellular matrix (ECM) proteins and cell-cell adhesion. Moreover, integrins constitute an important and functional bridge between the ECM and the cytoskeleton and are able to activate several intracellular signalling pathways. After the first report of their identification [1, 2], in the last 30 years, how the integrin protein family assumed a key role in mechanotransduction biology, particularly as mediators of a bidirectional signalling mode, has been extensively reported. Integrins are able to read and transmit signals from the extracellular microenvironment to the internal cellular milieu, including the cytoplasm and nucleus (outside-in), leading to a cellular reaction that may alter cell behaviour and/or also the composition of the ECM (inside-out). Several downstream mechanisms of integrins activate biochemical signalling cascades which have impact on different cell functions by regulating crucial molecular pathways involved in cell survival, proliferation, motility, and differentiation, both in physiological and pathological scenarios [36].

In 2007, the groundbreaking discovery of a universal protocol to reprogram mammalian somatic cells into induced pluripotent stem cells (iPSC) [7], made by Takahashi and colleagues, brought immense potential to the fields of regenerative and personalized medicine. In fact, these cells can differentiate into cell types from all the three developmental germ layers: ectoderm, mesoderm, and endoderm. iPSC-derived cells have modelled, previously unreproducible, human diseases, e.g., long QT (LQT) syndrome [8], and have already been used in two clinical trials for age-related macular degeneration [9] and advanced heart failure [10].

The efficacy of iPSC as a model system for the study of the molecular mechanisms guiding pathological development is tightly linked to the success of in vitro simulation of the environmental cues responsible for cell fate in vivo. Mechanosensing-mediated pathways are relevant not only for enhancing iPSC reprogramming efficiency [11] but also for supporting iPSC-derived cardiomyocyte (iPSC-d-CM) maturation [12]. Thus, several techniques have been proposed for the design of substrates regulating integrin activation by tuning chemical, geometrical, or mechanical parameters. The last part of this review is dedicated to the discussion of these methods and their relevance to spearheading the clinical translation of the iPSC technology.

2. Integrin Structure, Extracellular Ligands, and Focal Adhesion (FA) Complexes

The integrin family was firstly identified by using antibodies against integrin β subunits which unveiled several coimmunoprecipitating proteins. Integrin heterodimers are composed of noncovalently associated α and β subunits [3]. The heterodimeric structure and functionality of these receptors were made clear only after the use of specific peptides, e.g., arginine-glycine-aspartic acid (Arg-Gly-Asp; RGD tripeptide) and integrin α subunit-recognizing antibodies. To date, it is well known that the integrin family is constituted by 18 α subunits and 8 β subunits, possibly assembled in 24 different heterodimers [13]. Depending on integrin subunit composition, these molecules show specific extracellular ligand properties and can be classified into 4 main subgroups [14] listed in Table 1. This feature implies that the expression pattern of integrins is tissue specific [3]. In addition to a large extracellular domain, each heterodimer also has a transmembrane domain and a short cytoplasmic domain, which forms a fundamental functional link with the cytoskeleton [14].

Integrin heterodimersLigandsPathwayRef.

Collagen receptorα1β1Collagen (IV, I, and IX)(i) RhoA/ROCK[51]
α2β1Collagen (I, IV, and IX)(i) RhoA/ROCK
(ii) YAP/TAZ
α10β1Collagen (IV, VI, II, and IX)(i) RhoA/ROCK[51]
α11β1Collagen (I, IV, and IX)(i) RhoA/ROCK

Laminin receptorα3β1Laminin (LN-511, LN-332, and LN-211)(i) RhoA/ROCK[51]
α7β1Laminin (LN-511, LN-211, LN-411, and LN-111)(i) RhoA/ROCK
α6β1Laminin (LN-511, LN-332, LN-111, and LN-411)(i) RhoA/ROCK
α6β4Laminin (LN-332, LN-511)/

RGD receptorανβ1Fibronectin, vitronectin (RGD)(i) RhoA/mDia
ανβ3Vitronectin, fibronectin, and fibrinogen (RGD)(i) RhoA/mDia
(ii) MKL-1/SRF
(Responsible for the increase in the number of FA and cell spreading areas)
[17, 18, 50, 53]
ανβ5Vitronectin (RGD)(i) RhoA/mDia
(Responsible for the increase in the number of FA and cell spreading areas)
[17, 53]
ανβ6Fibronectin, TGF-β-LAP (RGD)/
ανβ8Vitronectin, TGF-β-LAP (RGD)/
α5β1Fibronectin (RGD)In the leading edge of moving cells in the 2D surface[16]
α8β1Fibronectin, vitronectin, and nephronectin (RGD)/
αIIbβ3Fibrinogen, fibronectin (RGD)/

Leucocyte-specific receptorα9β1Tenascin-C, VEGF-C, and VEGF-D/
α4β1Fibronectin, VCAM-1 (LDV)/
α4β7MadCAM-1 (LDV), fibronectin, and VCAM-1/
αDβ2ICAM-3, VCAM-1/
αLβ2ICAM-1, ICAM-2, ICAM-3, and ICAM-5/
αMβ2iC3b, fibrinogen/
αXβ2iC3b, fibrinogen/

As shown in Table 1, cells expressing β1 integrin are generally outbound to collagen when associated with α1, α2, α10, and α11 subunits. Otherwise, when β1 integrin is bound to laminin, it is complexed with α3, α6, and α7 subunits. Depending on which specific α subunit it heterodimerizes with, β1 integrin recognizes the RGD motif (ανβ1, α5β1, or α8β1) or leukocyte-specific receptors (α9β1, α4β1). All integrin heterodimers containing αν subunits are specifically associated with substrates with the RGD sequence. Similarly, all integrins expressing β2 subunit are members of the leukocyte-specific receptor-binding integrin subgroup. Lastly, α6β4 integrin belongs to the previously mentioned laminin receptor binding group [15].

It has been reported that β1 subunit-containing integrins, such as α5β1, are predominantly recruited to the leading edge of cells moving on a 2D surface [16], whereas β3 subunit-containing integrins are responsible for the increase in the number of focal adhesions (FA) and cell spreading area because of its role in structural reinforcement of adhesion [17, 18].

Since integrins work as receptors of several ECM components, they strongly contribute individually to FA-mediated signalling and rigidity sensing by mechanically changing their structural conformation. In external force mechanosensing, this integrin function can be considered as a primary step, followed by a series of secondary mechanosensor activities, which respond intracellularly to force-dependent alterations. Thus, extracellular tension transmitted through integrins elicits the binding of several intracellular elements, which in turn activate themselves and strengthen the integrin connection to actin (Figure 1(a)). Among these intracellular factors, the main ones involved in mechanotransduction are talin, vinculin, kindlin, α-actinin, zyxin, filamin, and p130Cas. The interaction of integrin cytoplasmic tails with one of these adaptor proteins, such as talin, is the main mechanism leading to full integrin activation. For example, talin, together with vinculin, plays a crucial role in the force-dependent stabilization of FA by changing its conformation after tension. Talin binds through its FERM (four-point-one protein/ezrin/radixin/moesin) domain to the NPxY amino acid motifs on integrin tails, inducing their activation [1921]. Vinculin presents a self-inhibited state, exerted by its head and tail domain interaction [22], and becomes activated after its tail domain binds to α-actinin alone or together with actin and phosphatidyl-inositol-4,5-bisphosphate (PIP2) [2326]. An increase in cellular tension, which is strictly related to ECM stiffness and cytoskeletal recruitment, stabilizes vinculin in the activated conformation, and leads to its FA recruitment [27, 28]. Another cooperating adaptor protein is kindlin which contributes to integrin activation [29, 30]. Until this link of the mechanotransduction chain, talin and vinculin act as direct mechanical sensors, able to feel ECM properties, while α-actinin, a spectrin superfamily component important for the structural organization of the cell, also provides a scaffold to connect the mechanotransduction chain with the previously mentioned downstream effectors [31]. Thus, α-actinin is an indirect link in the mechanotransduction chain. For this reason, cell stretching could result in the dissociation of several proteins that are weakly bound to α-actinin at multiple sites [32]. Among these weakly bound proteins, zyxin binds a central region of α-actinin [33]; when a certain type of mechanical stimulus occurs, this molecule translocates from FA to stress fibres [34]. Other connecting proteins between integrins and actin such as filamins [35] play a mechanoprotective role by stabilizing the actin cytoskeleton through linkage to the cytoplasmatic membrane. In fact, under mechanical stress, filamin domains change their conformational status considerably [36]. This event leads to extension and reversible unfolding [37], which allows filamin stretching and subsequent protection of the linkage between F-actin and the cytoplasmatic membrane [38]. Interestingly, force applied through clustered β1 integrins leads to the transcriptional upregulation of filamin A [39].

Lastly, Src family kinase p130Cas (Cas: Crk-associated substrate) contains a N-terminal SH3 domain, which binds the polyproline motifs of the tyrosine kinases, FA kinase (FAK) [40, 41], and other proteins such as vinculin [42]. The SH3 domain is followed by a large substrate domain with 15 repetitions of the YxxP motif (where x is any amino acid), which is a main site of tyrosine phosphorylation on the Cas molecule [43]. Once phosphorylated, the p130Cas SH3 domain serves as a docking site for the SH2 domains of Crk or Nck adaptor proteins [44, 45]. In nonadherent cells, p130Cas is localized in the cytoplasm and, after integrin receptor activation, translocates to FA where the phosphorylation of substrate domain tyrosine residues takes place [46]. p130Cas activation after integrin engagement regulates the reorganization of the actin cytoskeleton and cell processes, such as spreading and migration [47]. Moreover, this tyrosine phosphorylation triggers signalling pathways leading to the regulation of cell survival and proliferation [48, 49]. Recently, investigators highlighted how p130Cas is able to influence actin remodelling and concomitant muscle-specific gene expression [42, 50].

2.1. Mechanical Stress-Reactive Nuclear Complexes

Based on the previous discussion, it can be said that cells perceive, adapt themselves to, and modify the ECM microenvironment physical features by using specific protein structures including the mechanosensing machinery of cell-ECM and cell-cell interactions, secondary mechanosensors, and different mechanotransduction pathways. Interestingly, this mechanism is mediated by a direct effect of mechanical linkage which is specific and sufficient to transmit the extracellular stimuli into the nuclei [42, 54, 55].

The strong and intimate relationship between integrins, FA, actin cytoskeleton, and nuclear structures has been well documented in the last years. Several lines of evidence report that actin fibres communicate the mechanical properties of the internal cellular environment to the nucleus and consequently strongly affecting gene regulation and expression [56, 57]. The nucleus contains a stratified network of mediators, linking the nuclear envelope to the nucleoskeleton and chromatin (Figure 1(b)). Structural alterations of nuclei are responsible for gene modulation of multiple mediators such as those related to mechanotransduction and differentiation [58]. The nuclear lamina consists in filamentous lamin proteins (lamins A, B, and C) that form the mechanical support of the inner nuclear membrane. Several other membrane proteins, including LAP2, emerin, and MAN1, are essential nuclear constituents [59]. To date, it is well known that the cytoskeleton is strongly linked with the nuclear lamina [60]; nevertheless, most of the current information is derived from studies on isolated nuclei [61]. Two distinct protein families, the SYNE/nesprin family and the SUN family [62] colocalize in the nuclear membrane and are connected both with cytoskeleton and nuclear lamina. Studies on C. elegans revealed that homologues of nesprin 2 and SUN1/2 were associated with actin, at their N- and C-terminals, respectively. For this reason, the term LINC was coined, indicating that these protein structures were linkers of nucleoskeleton and cytoskeleton [63, 64]. Every molecular component of this important complex shows distinct binding peculiarity; while nesprins 1 and 2 are specialized in actin, microtubule, and kinesin binding, on the other hand, nesprins 3 and 4 are able to bind intermediate filaments and microtubules, respectively [6567]. Concerning the SUN protein family, the oligomerization as a trimer of these molecules is strongly required for nesprin binding [68]. These molecular events, which were experimentally observed on isolated nuclei, suggested their effectiveness in whole cell systems, thus supporting their contribution to mechanical cues. Thus, isolated nuclei react to the physical forces in a similar manner to complete cells, because of the presence of LINC complex, by which nuclei display adhesion ability acting as force-sensitive signalling hubs for cytoplasmic proteins and tuning nuclear responses to various mechanosensory inputs [61]. Finally, among LINC complex members, emerin plays a strategic role on the inner nuclear membrane, since it can be phosphorylated by Src kinases after a tension stimulus applied on isolated nuclei through nesprin 1 [61]. This event overlaps lamin A/C accumulation, which leads to the strengthening of the nuclear membrane. It is important to point out that Emery-Dreifuss muscular dystrophy is predominantly due to emerin gene mutations [69]; moreover, cells derived from emerin knockout transgenic mice show mechanotransduction impairments [62, 70].

2.2. Mechanosensing Signalling Pathways

The major chemical signals elicited by mechanical stress at the cell surface are as follows: (i) calcium influx through cation channels activated by stretch stimuli, (ii) activation of nuclear factor kappa-B (NF-κB), (iii) stimulation of mitogen-activated protein kinases (MAPKs), and (iv) changes in the activity of small GTPases, e.g., Ras, Rac1, and RhoA [7179].

Peculiar mechanisms have been unveiled, e.g., the adaptor protein p130Cas which is physically stretched in response to applied force both in vivo and in vitro. This stimulus exposes the previously masked phosphorylatable sites of p130Cas [80], that are substrates for Src family kinases which trigger further downstream responses [81].

Among the previously mentioned signalling pathways, there are two cascades which are strongly involved in the context of integrin-mediated mechanotransduction, namely, Rac1 and RhoA. In fact, these two members of the small Rho family GTPases regulate actin assembly and contraction [82, 83]. While active Rac1 controls actin polymerization at the leading edges of motile cells and is involved in lamellipodia focal complex formation, active RhoA is necessary for stress fibre formation. Notably, the two main RhoA downstream effectors are the diaphanous-related formin protein mDia1, a formin family member that serves as an actin nucleating factor and so facilitates actin polymerization and assembly [42, 8486] and the protein kinases ROCK-1 and ROCK-2, which promote actin contraction mediated by nonmuscle myosin-II [82, 83].

One important feature of Rac1 and RhoA is that each of these two mediators negatively regulates the other, leading to a discrimination of the activity in certain cell subareas [82], as depicted in Figure 2. Indeed, while some cell regions show higher Rac1 activity responsible for moving and protrusion, other subareas of the same cell with higher RhoA activity are more concentrated on adhesion and contraction. Several studies addressed the strong relationship between the integrin-dependent mechanical stress and the sustained modulation in Rac1 and RhoA activity [8791]. As previously mentioned, several information on different features of small GTPase response to integrin-derived mechanical stimulation are, to date, still missing, e.g., the exact signalling time course and the types of cells and stresses involved. However, it is well established that mechanical stimulation leads to small GTPase activity driving the cell to undergo a strong and complex actin cytoskeleton remodelling which also influences the adhesion features [92].

The main molecular events leading to the activation of these numerous pathways are considerably distinct and depend on the signal being activated. Activation of tyrosine kinases and protein tyrosine phosphorylation play crucial roles in the assembly and turnover of FA, as well as in mechanotransduction. FAK and members of the Src family are key tyrosine kinases, controlling FA functions and complex stability [93]. After integrin engagement, FAK is recruited to adhesion areas to provide both scaffolding and kinase activity. The autophosphorylation of FAK defines a docking site for Src kinase, which subsequently phosphorylates FAK on multiple tyrosine residues. All these events are helpful for full FAK activation [94]. Following this, the FAK-Src complex recruits the p130Cas protein and several other adaptor proteins, phosphorylating multiple residues on their sequence. After FAK autophosphorylation and the generation of docking substrates for the SH2 domains of the adaptor protein Crk (also known as p38), this interaction leads to the activation of downstream signalling cascades, such as Rac1 GTPase, previously reported as the pathway involved in actin polymerization and the formation of new focal complexes at the leading edge of the cell [95, 96]. It has been demonstrated that inhibitors of actomyosin contractility lead to a loss of tension due to a rapid dismantling of FA [23, 27]. Mechanical tension activates guanine nucleotide exchange factors (GEFs) for Rho, such as Vav2, GEF-H1, or LARG, which subsequently induce GTP loading of Rho. This leads, in turn, to the activation of downstream effectors ROCK and mDia. Furthermore, several integrins containing β1 subunits (e.g., α5β1) activate the pathway mediated by Rho-ROCK-myosin-II to induce forces mediated by actomyosin (Figure 2), whereas αν subunit-containing integrins, e.g., ανβ3 and ανβ5, are more involved in external force adaptation and regulate both the stress fibre synthesis and FA area expansion through the pathway mediated by Rho-mDia [97]. ROCK-mediated activation of myosin light chain, together with inhibition of myosin light chain phosphatase, rapidly increases myosin-II activity and actomyosin contractility (Figure 2). Overall, ROCK activity leads to actin stress fibre stabilization.

3. Integrins and iPSC

Human embryonic stem cells (ESC) and iPSC, obtained by somatic cell reprogramming, are promising pluripotent stem cells, with the potential for recapitulating monogenic diseases and producing cell-based therapies [98]. In order to maximize the full potential of these cells, it is mandatory to enhance investigation and knowledge on the best culture conditions able to maintain plasticity, self-renewal, and external stimuli responsiveness as well as attenuate cell death events. Despite the lack of knowledge, there is increasing evidence regarding the contribution of integrins on pluripotent cell-ECM interaction [98101].

The intricate and incompletely understood nature of cell fate and potency routes was succinctly represented in the self-acknowledged oversimplified [102] Waddington diagram [103] which is based on original artwork created by John Piper [104]. We have reimagined this iconic diagram to better summarize integrin engagement for cell-cell and cell-ECM binding and how these interactions affect cell fate (Figure 2). Mechanisms governing the transition from a somatic cell to an iPSC, which is initiated by the expression of exogenously acquired transcription factors, are continuously evolving, and much effort is directed to optimize the stochastic process of cell fate rewinding, in order to achieve a fully predictable process [105]. Reprogramming involves three sequential steps: initiation, stabilization, and maturation [106]. Indeed, molecular mediators, e.g., microRNA, or biophysical cues, e.g., nanotopography, can supplement or replace some of the classical reprogramming factors commonly used to enhance reprogramming efficiency [107113].

In this context, the activation of the transforming growth factor-β (TGF-β) pathway and the expression of E-cadherin are of interest. While the former is a potent inhibitor of mesenchymal-to-epithelial transition, which is essential for a successful reprogramming [114], the latter is not only important for the maintenance of pluripotency and proper colony morphology but is also an absolute requirement for iPSC generation as well as the primary gatekeeper to the differentiation progression [115]. Moreover, iPSC kinome-wide functional analysis during reprogramming found a critical role in the cytoskeletal remodelling process. Specifically, the key serine/threonine kinases, testicular protein kinase-1 and LIM kinase-2, phosphorylate the actin-binding protein cofilin to modulate the cell reprogramming process.

Attempts have been made to transfer from the traditional 2D culture of iPSC to 3D culture in large-scale bioreactors, a step which would facilitate iPSC culture on industrially and clinically relevant scales [116, 117]. Since iPSC normally exist in tightly packed colonies, their dissociation into single cells, which is needed to ensure uniform cell distribution and diffusion of treatments, is a major stressor and initially caused high rates of cell death before the routine use of ROCK inhibitors during passaging [118]. Indeed, approaches that prevent actin-myosin contraction, such as downregulation of myosin heavy or light chains and ROCK inhibition [119], protect cells from cell death processes. Moreover, it has been demonstrated that a direct inhibition of Rho-ROCK-myosin-II activation involving E-cadherin leads to a uniform differentiation of pluripotent stem cell colonies [115].

To date, the generation of iPSC in two parallel states of pluripotency has been described: naïve and primed [120]. Naïve iPSC are considered closer to a ground state, similar to preimplantation epiblasts, while primed iPSC correspond to cells found in the postimplantation epiblasts which are ready or “primed” to differentiate [121123]. The importance of the pluripotency state is crucial to understand and to harness in research field, as it is currently appreciated that naïve and primed states have differing biological functions, e.g., developmental potency and chimeric contribution ability [124]. However, most of human iPSC are cultured in a primed state; therefore, much attention focuses on defining the factors (frequently soluble factors) that can revert primed cells to a naïve state [125129]. A major driver to appreciate the role of culture substrates in pluripotency continuum came from the clearly recognizable morphological differences in naïve and primed colonies: naïve cells form dome-shaped 3D colonies, while colonies consisting of primed cells possess a flattened appearance. Despite the lack of information on the effect of growth substrates on the pluripotency status, suppression of ECM-integrin signalling has been linked to the maintenance of naïve human iPSC [130, 131].

Much of the information concerning ESC- and iPSC-integrin interaction stems from the gradual transition of feeder layer-cultured cell lines to more defined matrices such as Matrigel®, Cultrex BME®, Geltrex®, fibronectin, collagen IV, laminins, and vitronectin. A comparison of ESC and iPSC mRNA microarray data revealed that the expression profiles of integrins are similar in both types of pluripotent stem cells. Specifically, α5, α6, αν, β1, and β5 are all abundantly expressed on iPSC; however, not all iPSC lines displayed identical integrin profiles [132, 133]. Similarly, the integrin α3, α5, α6, α9, αν, and β1 subunits, but not the α1, α2, α4, α7, and α8 subunits, were identified as markers of undifferentiated porcine-primed ESC, with a subsequent significant increase in their adhesion features on fibronectin, tenascin C, and vitronectin coatings. The blockade of integrin heterodimers α5β1, α9β1, and ανβ1 lead to a strong inhibition in cell-ECM adhesion [134]. Moreover, ανβ3, α6β1, and α2β1 play a significant role in the initial adhesion of the human ESC to Matrigel [135]. Interestingly, human but not porcine ESC display the active integrin heterodimer α6β1 [136] suggesting species-dependent differences in the mechanotransduction signalling context. Concerning iPSC features, the parental cell-type origin impacts integrin expression, with enhanced levels of certain integrins observed in iPSC derived from adherent cell types, e.g., foreskin fibroblasts. Interestingly, Rowland and colleagues uncovered important differences between human ESC and iPSC in terms of the essential integrins necessary for initial adhesion and subsequent proliferation on different matrices. Specifically, they showed that β1 is necessary for both functions when each cell type was grown on Matrigel® whereas ανβ5 and β1 are important for iPSC attachment and proliferation when cultured on vitronectin as described in Section 2. Lastly, integrins and integrin-mediated signalling are important in maintaining iPSC self-renewal and pluripotency as indicated by reduced Nanog, Oct-4, and Sox2 levels in α6-silenced iPSC lines, localization of the FAK N-terminal domain in nuclei, and AKT signalling activation [136, 137]. Similarly, murine ESC interaction with the RGD peptide plays a role in the expression of core transcription factors, i.e., Oct-4, Sox2, and Nanog. Cyclic RGD synthetic compound supplementation was sufficient to mimic the effect of a mechanical stimulus, in terms of pluripotent gene expression. Specifically, this molecule or mechanical stimulus significantly influenced ESC pluripotency by downregulating core transcription factors. Moreover, RGD peptide, by inhibiting integrin binding and, in turn, integrin expression [6], upregulated early lineage markers (mesoderm and ectoderm) by leukaemia inhibitory factor (LIF) signalling [138]. Interestingly, human ESC, expressing integrin α6β1, preferentially bind human recombinant laminin-111, laminin-332, and laminin-511, which are good substrates able to maintain undifferentiated pluripotent human ESC cultures [139].

The ultimate destination of iPSC is differentiation along specific cell lineages culminating in the generation of functional terminally differentiated cells. Tailored protocols now exist to generate most cell types from each of the three germ layers, e.g., neurons, pancreatic islet β-cells, and, of specific relevance to this review, cardiomyocytes. Subsequently, these iPSC-derived cells can be used to model various diseases and screen novel drugs. Early cardiomyocyte differentiation protocols relied on the appearance of beating clusters within stochastically formed embryoid bodies (EB). The inefficient nature of producing cardiomyocytes from EB leads to the discovery of more efficient methods for cardiogenesis. One option considered here is the employment of small molecules modulating the key stages of embryonic cardiac development, i.e., early mesoderm formation by molecules targeting bone morphogenetic proteins, the wingless/INT (Wnt) proteins, and fibroblast growth factors, followed by activation of the conserved cardiac transcriptional program, i.e., Nkx2.5, Tbx5, Isl1, GATA4, and SRP. This program ultimately leads to the expression of the structural proteins essential for the function of cardiomyocytes, e.g., actin, myosin light/heavy chains, desmin, and the troponins (elegantly reviewed in [140]). Zeng et al. demonstrated that EB growth and cardiac differentiation of EB rely on collagen/integrin β1 interaction [141]. Specifically, they observed a synergistic upregulation of collagen and integrin β1 which peaked on the third post differentiation induction day [141]. Interestingly, the size and shape of EB as well as the confluence of iPSC are strongly linked to cardiogenic capacity [142146]. The Wnt pathway is a pivotal pathway strongly linked to iPSC self-renewal and differentiation which is exploited by cardiomyocyte differentiation protocols relying on its temporal activation and inhibition in order to achieve highly efficient cardiomyogenesis [145, 147]. The noncanonical Wnt-planar cell polarity (PCP) pathway is able to induce actin cytoskeleton change promotion through Rac1, RhoA, and small GTPase signalling, which controls cell movement and tissue geometrical features. Good examples are the RhoA signalling cascade activated by DAAM1 and DAAM2 formin homology proteins or the JNK signalling cascade, which is activated by MAPKKK and MAPKK 4/7 [148, 149]. Critically, following prolonged Wnt/β-catenin activation, the E-cadherin suppressors, SLUG and SNAIL, act as watershed factors that turn the iPSC fate from self-renewal to committed differentiation [150]. Lastly and more interestingly, for the clinical relevance, is the observation of Zhao and colleagues [151] who showed that the ROCK inhibitor, Y-27632, enhanced the transplantation success (in terms of engraftment) of human iPSC in a murine myocardial infarction model. The same compound revealed positive effects also on human ESC, e.g., increasing migration and supporting differentiation into EB. In the same study, integrin β1 blockade abolished the adhesion of ESC which decreased their survival and pluripotent status [152].

3.1. Mechanotransduction and Cell Differentiation

The genes under the direct control of the signalling pathways described in Section 3 are multiple. In this section, we will focus on the genes and pathways involved in pluripotent stem cell differentiation into cardiomyocytes.

An interesting 2013 study highlighted how integrin-mediated response to strain can be modulated by cell geometry more than by the cell area. Indeed, given the relevance of cell geometrical cues in mechanotransduction, in several cell types, efficient RhoA activation leads to megakaryocytic leukaemia-1 (MKL-1) protein translocation into the nucleus, in a cell shape-independent manner [153]. MKL-1 is a member of the so-called myocardin-related transcription factor family and physically interacts with the serum response factor (SRF) which activates SRF-dependent downstream gene transcription [154], e.g., actin cytoskeletal/FA-related proteins [155, 156].

In a previous study, it was shown that the skeletal α-actin promoter activation, which is downstream of RhoA, was strongly potentiated by β1 integrin expression and function. These events were demonstrated to be specifically displayed by cardiomyocytes, but not by NIH 3T3 fibroblasts. This observation further supported RhoA/SRF-dependent cardiomyocyte gene expression by the β1 integrin signalling pathway [157]. Concerning the role of SRF in stem cells, the study of murine SRF ESC showed that SRF deficiency causes impairments in cell spreading, adhesion, and migration, due to cytoskeletal structure modifications in terms of actin stress fibres and FA. Moreover, stem cells lacking SRF displayed downregulated FA, FAK, β1 integrin, talin, zyxin, and vinculin [158]. Furthermore, depletion of the adhesion molecule integrin β3, a key regulator of myogenic differentiation and actin organization, attenuated p130Cas phosphorylation and MKL nuclear localization during myoblast in vitro differentiation [50].

The MKL-1/SRF pathway is firmly linked to another important signalling pathway, strongly involved in mechanosensing in cardiovascular cells, namely, yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) [159, 160]. Tuning YAP transcriptional activity leads to the modification of cell mechanics, force, and adhesion and determines cell shape, migration, and differentiation [161]. In the last years, this signalling pathway, deeply related to the HIPPO pathway, which is strongly related to developmental biology, is a hot topic in mechanotransduction studies. Indeed, there are numerous papers describing the involvement of YAP/TAZ in osteogenesis [159, 162].

Several studies underlined the indirect role of small GTPase Rho in YAP/TAZ nuclear localization control, exerted by promoting the actin bundles and stress fibre formation in response to cell spreading on the ECM [163165]. Nardone et al. in 2017 demonstrated that YAP nuclear localization is controlled through Rho/ROCK activation and YAP transcriptionally controls FA formation and cytoskeleton stability which, in turn, determines cell adhesion to the ECM [161].

Experiments on conditional mouse YAP and TAZ in the skin resemble the profibrotic phenotype of skin-specific loss of integrin β1, highlighting the strong linkage and interplay of all these molecules in vivo [166].

Recently, β1 integrin-dependent cell adhesion was seen as a critical element in mesenchymal cell proliferation, both in vivo and in vitro. In fact, it was demonstrated that β1 integrin-dependent activation of the small GTPase Rac1 leads to YAP dephosphorylation and its nuclear shuttling, confirming that β1 integrin-dependent Rac1 function plays a key role in YAP regulation, triggered by cell adhesion [167]. Another recent paper identified a pathway involving both activation of integrin α3 and a FAK cascade-controlling YAP phosphorylation and thus its nuclear localization in transit-amplifying stem cells. In this work, the authors highlighted that this specific signalling pathway potentiates mTOR signalling, driving cell proliferation, and that the YAP/TAZ signalling mechanism coordinates stem cell expansion and differentiation during organ self-renewal [51].

4. Integrin Relevance in iPSC-Derived Cells: In Vitro Biomimetic Approaches

As discussed in the first section, mechanosensing, in general and specifically integrin activation, can be used to guide lineage-specific cell fate by activating mechanotransduction pathways. In order to better elucidate the fundamental mechanisms driving pathophysiological mechanisms, several in vitro models, based on biomimetic approaches, have been proposed and discussed. This section provides an overview of the in vitro models (Figure 3), focusing on the potential of biomimetic approaches to direct iPSC cardiomyocyte differentiation and maturation, possibly supporting their use in the field of cardiovascular regenerative medicine and tissue engineering.

4.1. Surface Chemistry

Substrate chemical composition and the motifs decorating a given surface have a strong effect on selective integrin engagement. Here, we will discuss two different approaches to engineering substrates: the first employing ECM obtained by decellularization of biological tissues and the second relying on the functionalization of synthetic biomaterials.

4.1.1. Decellularized ECM

In vivoECM, thanks to its chemical composition and mechanical/topographic properties, establishes the bases to support cell proliferation and differentiation [168, 169]. Indeed, the ECM surface does not only mediate cell attachment by exhibiting anchorage sites for different cell surface receptors and coreceptors but also regulates the diffusion of soluble factors secreted by the neighbouring cells, e.g., ECM composition modifies chemical diffusion coefficient and, as a product of its own remodelling, releases functional fragments constituting additional soluble factors.

For this reason, the use of decellularized tissues, maintaining composition, architecture, mechanical properties, and, interestingly, cell-binding domains, has been widely proposed as a suitable scaffold for in vitro cell seeding, expansion, and differentiation [170174]. In parallel, its specific capacity to guide stem cell differentiation has been also shown [168, 175177]. In particular, the ability to selectively increase the expression of integrins [171] has been demonstrated, underlining the relevance of ECM protein composition, e.g., the ratio of collagen, fibronectin, laminin, vitronectin [178], and their topology, supporting cell adhesion and subsequently stimulating controlled cell differentiation [171]. The potentiality of scaffolds realized by tissue decellularization is maximized by the use of dynamic culture methods, i.e., perfusion bioreactors supporting homogeneous repopulation of the whole scaffold volume [179181] and recreating a controlled and reproducible 3D environment.

Nevertheless, although experiments are performed under highly controlled culture conditions, the coexistence of multiple parameters limits the understanding of the impact of specific factors. Therefore, decellularized ECM scaffolds are good multifactorial model systems, comprehensive of the complexities of the in vivo scenarios, and are suitable for translational studies. On the other hand, biomaterials have been designed and functionalized ad hoc, by means of either coating with ECM components or generating specific cell-binding domains, in order to interpret different mechanisms.

The intermediate link in this chain is constituted by 3D bioprinting technologies. The technological advances in the field have allowed the use of liquefied decellularized tissues for high-resolution precise simulation of native tissue structures, with encapsulated cells [182, 183], thus providing the chance to observe the biological effects induced by fine tuning of local chemical/architectural matrix modifications.

4.1.2. Engineered Biomaterials

Polymers, both synthetic and natural, have been widely used for the manufacture of substrates and scaffolds intended for in vitro cell culture and cardiovascular tissue engineering [184]. The most used synthetic polymers in the field are poly(ethylene-glycol) (PEG), poly(lactic-acid) (PLA), poly(glycolic-acid) (PGA), poly(ε-caprolactone) (PCL), and their copolymers such as poly(lactide-co-glycolide) (PLGA) and polyurethanes (PU) [185190]. In contrast, natural materials include ECM constituents, i.e., collagen, fibrin, and silk [178, 191, 192]. The advantages of using engineered biomaterials rely on their amenability to fine-tune parameters, such as biocompatibility, local rigidity, micro/nanoarchitecture, and functionalization with ECM proteins, integrin-binding peptides, or growth factors [186, 193].

By coating synthetic materials, e.g., PU, with fibronectin (REDV, PHSRN, RGD, and GRGDSP), laminin (IKLLI, IKVAV, LRE, PDSGR, RGD, and YIGSR), and collagen (DGEA) sequences [194196] together with supplementing cell culture media with selective integrin inhibitors [197], the effect of integrin expression on cell attachment and proliferation has been highlighted. In addition, polymer functionalization with ECM peptides has been proposed to actively promote cell differentiation. An example, performed with an elegant and innovative approach, has been proposed by Ovadia and colleagues [198]. Matrigel®, a commercial solubilized basement membrane preparation extracted from the Engelbreth-Holm-Swarm mouse sarcoma cells, consisting of laminin, collagen IV, proteoglycans, and a number of growth factors, is widely recommended as an iPSC culture support. However, the specific reasons behind its success have not been elucidated. In their work, Ovadia et al. proposed iPSC single-cell encapsulation within 3D photopolymerized with UV light (365 nm for 2 minutes) PEG-peptide-based synthetic gels conveniently functionalized by a range of motifs inspired by Matrigel and known to bind a variety of integrins (including α6, αν, and β1), which generally promotes cell adhesion. Knowing that ROCK inhibition increases the expression of αν, α6, and β1 integrins during iPSC culture on Matrigel®, in the proposed 3D culture system, the authors showed that iPSC viability, growth, and differentiation were enhanced in response to the environment, in particular to β1 integrin activation.

Another parameter that needs to be taken into account when modelling cell adhesion in vitro is the coupling strength between integrin ligand and substrate. Human mesenchymal stem cells exhibit enhanced osteogenesis in response to high-strength binding which results from the activation of a YAP-mediated pathway [199]. This result suggests that traditional covalent biological coatings could generate a bias in data interpretation, which implies the need for novel coating methods, such as noncovalent coatings [200]. Based on these findings, it is clear that the study of integrin recruitment can not omit the consideration of forces acting on the whole chain, from the substrate, e.g., substrate rigidity to the engaged cytoskeleton filaments. Combinatorial approaches have been implemented for the production of copolymers able to tune cell-substrate interaction. An example of this approach is provided by Cheng et al. [201], who demonstrated that novel supramolecular PCL-containing self-complementary sextuple hydrogen-bonded uracil-diamidopyridine moieties can positively support cell attachment and proliferation. Moreover, as demonstrated by Chun et al. in 2015 [202], the copolymer generated by polymerization of monomeric ε-caprolactone with methoxy-PEG, in the ratio of 4% PEG-96% PCL, was able to enhance iPSC-d-CM contractility, upregulating the expression of mature cardiomyocyte markers such as myosin light chain-2ν and cardiac troponin I. The authors demonstrated that these effects are linked to the engagement of a subset of integrins which activate a mechanosensory transduction pathway regulated by the polymerization of intermediate filaments.

4.2. Surface Topography

In vivo cardiac tissue functionality is aided by the anisotropic tissue structure which results from ECM protein organization, cell orientation, and cell-ECM/cell-cell junctions. In vitro, the relevance of ECM architecture in iPSC maturation has been demonstrated by means of micro- and nanostructured substrates. Results demonstrated how geometrical cues could support iPSC pluripotency and differentiation [203, 204] by the formation of cell-cell junctions, not only leading to the generation of more functional grafts, increased beating rate, and enhancing tissue-specific protein arrangement, e.g., sarcomeric-actinin, connexin 43, and troponins, but also allowing better stratification of the pathology, e.g., muscular dystrophy [203, 205207].

At the aim of understanding the involvement of integrins in geometrical feature-driven cell differentiation, substrates controlling either cell shape and size or cell alignment or spacing of adhesion ligands have been designed.

4.2.1. Cell Alignment

In vivo, physiological cardiac functionality is supported by coordinated muscular contraction, which is allowed by highly organized cell alignment, guaranteeing controlled anisotropic conduction of the electrical stimuli. In vitro iPSC-d-CM assemble in heterogeneous randomly organized clusters, missing accurate reproduction of the in vivo scenario. This limits their level of maturation and excludes from the in vitro model the effects of possibly relevant mechanotransduction-guided mechanisms. The introduction of nanotopographical features into culture substrates, i.e., grooves in the 700–1000 nm range [11], has been demonstrated to improve cardiomyocyte development by acting on one hand through a reorganization of the integrin activation of the single iPSC (i.e., enhancing integrin expression and formation of FA and increasing F-actin polymerization) and, on the other, geometrically organizing the colony polarization. Culturing on grooved substrates finally impacts on iPSC-d-CM intrinsic molecular machinery, i.e., through the activation of the YAP-dependent pathway [208, 209], resulting in more physiological behaviours, showing a reduction of arrhythmias and inducing more mature Ca2+ spark patterns [210, 211]. The maturity level not only would benefit from cell alignment but could permit a more significant stratification of the pathology, as demonstrated by the limited capacity of iPSC-d-CM from patients affected by Duchenne muscular dystrophy versus healthy donors in their ability to reorient when cultured on grooved substrates [212].

More recently, the introduction of polymeric nanowires offers the chance to couple cell alignment with electrical conductivity and stimulation, reproducing preferential routes for geometrical organization and electrical signal timing. The application of this technology resulted in a significantly more advanced cellular structure, i.e., showed by cell-cell junction formation, and contractile function efficiency [213215], enhancing in vitro iPSC-d-CM maturation and functionality and leading towards the design of a better model system for the evaluation of the in vivo pathophysiological mechanisms.

4.2.2. Cell Shape and Size

In between, the geometrical features able to guide in vitro stem cell differentiation, shape, and size have been widely studied [216]. Indeed, several screening platforms, also commercial platforms, e.g., BioSurface Structure Array, Nano-TopoChip [217], have been used to demonstrate that by regulating the width/length ratio, in the presence or absence of soluble factors, cell fate can be moved from osteogenic to adipogenic commitment.

Regarding iPSC, they are often cultured as aggregates and not as single cells; therefore, the mechanotransduction-driven effects of whole-colony size and shape should be taken into account. Indeed, by controlling colony size, density, shape, and spacing, Myers et al. [218] improved homogeneity in the expression of pluripotency markers (SSEA4 and Nanog). Moreover, the proposed micropatterning technique, through the standardization of cell density, increased the percentage of spontaneous beating cells. In particular, the generation of circular patterns leads to the formation of connecting rings of cardiomyocytes, supporting in vitro physiological electrical behaviour, i.e., supporting the propagation of contractile waves throughout the ring. Another example of how cell shape, coupled with the supracellular structure, can be used to promote in vitro cardiomyocyte maturation is provided by the work of Xu et al. [211]. Here, by imposing single-cell elongation by culturing on silicon-patterned substrates, FA can be regulated to support alignment and cell-cell contacts leading to increased cardiac differentiation efficiency. Moreover, in their recent work, Grespan and colleagues [203] cultured iPSC onto microstructured (square micropillars) silicon substrates and observed that, while not affecting pluripotency, nuclear deformability is sensibly regulated during germ layer specification, happening during iPSC differentiation.

These observations, taken together, finally call for the design of more complex in vitro substrates, taking into account mechanosensing mechanisms for better iPSC differentiation.

4.2.3. Integrin Clustering Methods

The methods described in the previous paragraphs are based either on functionalization of substrates by random decoration with integrin-binding domains or by induction of adhesion sites by geometrical constraint and do not encompass the relevance of integrin geometrical distribution. It has been made possible to involve this aspect thanks to the development of novel nanotechnologies, which can be divided in three different approaches [219]: (i) blending of polymers with different degrees of ligand incorporation [220, 221], (ii) nanoprinting lithography of nanoparticle arrays [222224], and (iii) transfection of proteins by chimera constructs [225]. Results demonstrated that not only identity, abundance, and density of adhesion sites but also their spatial confinement, including global and local density, regulate cell adhesion [226], migration, proliferation, and differentiation acting on both cell-substrate and cell-cell contact [224]. Furthermore, the capacity of nanoscale spatially organized cell-adhesive ligands to direct stem cell fate was also demonstrated [210, 227].

4.3. Surface Elasticity

Substrate stiffness has been shown to be a very strong mechanotransduction stimulus, regulating physiopathological cell behaviour and cell reprogramming and subsequently guiding the development of mature cell phenotypes [164, 228233]. In particular, regarding the in vitro application of iPSC technology in the cardiac field, matrix rigidity can guide iPSC-d-CM differentiation: the use of a substrate with compliance similar to that of native cardiac tissue [234236] supports cardiac commitment and enhances metabolic maturity, sarcomeric protein subtype, cardiac troponin T expression, and force generation [230, 235, 237, 238]. The molecular events transferring the force from the substrate to the nuclei, through cytoskeleton engagement, have been described by Zhou et al. [239], and other reviews discussed this topic at length [240, 241]. Here, we will underline some specific aspects about the involvement of integrins in this phenomenon. Indeed, the selective switching from the activation of β3 to β1 integrins in response to reduced substrate stiffness has been demonstrated [197, 242, 243]. From a technological point of view, it is interesting to underline the sensitivity of the whole traction chain to integrin-substrate binding force. Indeed, a modification in the substrate-anchoring strength of integrin-binding ligands, i.e., choosing covalent binding to obtain stable substrate coating, could lead to a misinterpretation of in vitro cell behaviour [15, 199, 244, 245], thus highlighting the importance of considering mechanical stimuli, i.e., surface elasticity, with the feeling of cells, recognizing the role of all the nanoscale players.

4.4. Mechanical Stimulation

Mechanical stimulation has been demonstrated to regulate FA assembly, modulating the downstream pathways affecting cardiomyogenesis [246249]. Based on this assumption, several methods have been described for the application of controlled mechanical stimulation (i.e., temporal, spatial, and amplitude), some of them aiming to verify the positive impact of integrin-mediated adhesion pathways on iPSC reprogramming [113] and differentiation [250, 251]. Although far from being exhaustively described, the pathways seem to be regulated by the change in FA density and local conformation [252], followed by impacting cytoskeleton rearrangement [56], finally regulating cardiomyocyte maturity, e.g., cell-cell contact, sarcomeric structure, and electrical activity. As an example, the interconnection between the mechanical stimulation, in particular shear stress, and the modulation of cellular electrical activity was demonstrated by Roy and Mathew [253], who underlined how the gene encoding the α-subunit of human ether-a-go-go-related gene (hERG) potassium ion channel could be modulated by integrins via a mechanoelectric feedback pathway. Not only that mechanical stimulation enhances cell electrical behaviour but that a positive effect on maturation of cardiomyocytes in vitro has been demonstrated by coupling pacing with mechanical stimulation [254]. Finally, the in vitro implementation of mechanical stimulation has been shown of benefit in the model for the pathology stratification. Chun and colleagues proposed [249] that the application of cyclic or static strain modulated the gene expression of a cell-cell connection-related protein (connexin-43) in iPSC-d-CM which was more pronounced in iPSC-d-CM from patients affected by primary dilated cardiomyopathy.

5. Conclusions

Each integrin type is coupled to a different combination of signalling cascades which drive specific cellular processes, e.g., stem cell differentiation [255, 256]. Integrins are involved not only in the recognition of substrate composition but also in sensing ECM rigidity and adapting cell morphology, motility, and fate to the mechanical properties of the matrix, through the activation of mechanotransduction pathways.

However, the high specificity in the link between integrin-mediated cell response to tissue-specific microenvironment is far from being completely decrypted, both in general [15] and more specifically in pluripotent stem cells [98]. A detailed understanding of the cellular machinery linking mechanosensing to mechanotransduction would be beneficial for effective in vitro modelling and the future clinical translation of tissue-specific differentiated iPSC.

As discussed in this review, the implementation of in vitro novel biomaterials, taking into account integrin-mediated mechanotransduction signalling, coupled with controlled systems, i.e., microfluidic bioreactors, could be relevant to improving the study of iPSC-d-CM differentiation and supporting maturation [12, 257], inspired by an “organ/lab-on-chip” approach [227]. The design of such models would benefit (i) in vitro modelling of the molecular basis of the pathologies, (ii) in vitro evaluation of possible mechanisms and specific molecular targets for personalized pharmacological approaches, and (iii) development of a mature cell source available for future transplantation perspectives. Indeed, the high risk of teratoma formation intrinsic to transplantation of iPSC-derived cells is well acknowledged. Moreover, the maturity of the implanted cells, especially thinking about cardiac applications of iPSC-d-CM, should guarantee their survival and functionality shortly after the procedure.

In conclusion, these aspects would raise the level of iPSC-d-CM quality and provide an effective model system for the study of different cardiac pathologies. Moreover, in an optimal scenario, the use of bioactive scaffolds in controlled culture systems could permit the utilization of read-out parameters that provide a culture quality feedback signal.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

R. Santoro and G.L. Perrucci contributed equally to this work.


This work was supported by the Italian Ministry of Health Ricerca Corrente to Centro Cardiologico Monzino IRCCS (RC 2017/18).


  1. J. W. Tamkun, D. W. DeSimone, D. Fonda et al., “Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin,” Cell, vol. 46, no. 2, pp. 271–282, 1986. View at: Publisher Site | Google Scholar
  2. R. O. Hynes, “Integrins: a family of cell surface receptors,” Cell, vol. 48, no. 4, pp. 549–554, 1987. View at: Publisher Site | Google Scholar
  3. R. O. Hynes, “Integrins: bidirectional, allosteric signaling machines,” Cell, vol. 110, no. 6, pp. 673–687, 2002. View at: Publisher Site | Google Scholar
  4. G. L. Perrucci, E. Rurali, and G. Pompilio, “Cardiac fibrosis in regenerative medicine: destroy to rebuild,” Journal of Thoracic Disease, vol. 10, Supplement 20, pp. S2376–S2389, 2018. View at: Publisher Site | Google Scholar
  5. G. L. Perrucci, M. Zanobini, P. Gripari et al., “Pathophysiology of aortic stenosis and mitral regurgitation,” Comprehensive Physiology, vol. 7, no. 3, pp. 799–818, 2017. View at: Publisher Site | Google Scholar
  6. G. L. Perrucci, V. A. Barbagallo, M. Corlianò et al., “Integrin ανβ5 in vitro inhibition limits pro-fibrotic response in cardiac fibroblasts of spontaneously hypertensive rats,” Journal of Translational Medicine, vol. 16, no. 1, p. 352, 2018. View at: Publisher Site | Google Scholar
  7. K. Takahashi, K. Tanabe, M. Ohnuki et al., “Induction of pluripotent stem cells from adult human fibroblasts by defined factors,” Cell, vol. 131, no. 5, pp. 861–872, 2007. View at: Publisher Site | Google Scholar
  8. I. Itzhaki, L. Maizels, I. Huber et al., “Modelling the long QT syndrome with induced pluripotent stem cells,” Nature, vol. 471, no. 7337, pp. 225–229, 2011. View at: Publisher Site | Google Scholar
  9. M. Mandai, A. Watanabe, Y. Kurimoto et al., “Autologous induced stem-cell-derived retinal cells for macular degeneration,” The New England Journal of Medicine, vol. 376, no. 11, pp. 1038–1046, 2017. View at: Publisher Site | Google Scholar
  10. S. Miyagawa, K. Domae, Y. Yoshikawa et al., “Phase I clinical trial of autologous stem cell-sheet transplantation therapy for treating cardiomyopathy,” Journal of the American Heart Association, vol. 6, no. 4, 2017. View at: Publisher Site | Google Scholar
  11. D. Carson, M. Hnilova, X. Yang et al., “Nanotopography-induced structural anisotropy and sarcomere development in human cardiomyocytes derived from induced pluripotent stem cells,” ACS Applied Materials & Interfaces, vol. 8, no. 34, pp. 21923–21932, 2016. View at: Publisher Site | Google Scholar
  12. Y. Li, L. Li, Z. N. Chen, G. Gao, R. Yao, and W. Sun, “Engineering-derived approaches for iPSC preparation, expansion, differentiation and applications,” Biofabrication, vol. 9, no. 3, article 032001, 2017. View at: Publisher Site | Google Scholar
  13. Y. Takada, X. Ye, and S. Simon, “The integrins,” Genome Biology, vol. 8, no. 5, p. 215, 2007. View at: Publisher Site | Google Scholar
  14. M. Barczyk, S. Carracedo, and D. Gullberg, “Integrins,” Cell and Tissue Research, vol. 339, no. 1, pp. 269–280, 2010. View at: Publisher Site | Google Scholar
  15. S. Seetharaman and S. Etienne-Manneville, “Integrin diversity brings specificity in mechanotransduction,” Biology of the Cell, vol. 110, no. 3, pp. 49–64, 2018. View at: Publisher Site | Google Scholar
  16. C. G. Galbraith, K. M. Yamada, and J. A. Galbraith, “Polymerizing actin fibers position integrins primed to probe for adhesion sites,” Science, vol. 315, no. 5814, pp. 992–995, 2007. View at: Publisher Site | Google Scholar
  17. P. Costa, T. M. E. Scales, J. Ivaska, and M. Parsons, “Integrin-specific control of focal adhesion kinase and RhoA regulates membrane protrusion and invasion,” PLoS One, vol. 8, no. 9, article e74659, 2013. View at: Publisher Site | Google Scholar
  18. H. B. Schiller and R. Fassler, “Mechanosensitivity and compositional dynamics of cell-matrix adhesions,” EMBO Reports, vol. 14, no. 6, pp. 509–519, 2013. View at: Publisher Site | Google Scholar
  19. D. A. Calderwood, B. Yan, J. M. de Pereda et al., “The phosphotyrosine binding-like domain of Talin activates integrins,” The Journal of Biological Chemistry, vol. 277, no. 24, pp. 21749–21758, 2002. View at: Publisher Site | Google Scholar
  20. C. Kim, F. Ye, X. Hu, and M. H. Ginsberg, “Talin activates integrins by altering the topology of the β transmembrane domain,” The Journal of Cell Biology, vol. 197, no. 5, pp. 605–611, 2012. View at: Publisher Site | Google Scholar
  21. J. H. Wang, “Pull and push: talin activation for integrin signaling,” Cell Research, vol. 22, no. 11, pp. 1512–1514, 2012. View at: Publisher Site | Google Scholar
  22. W. H. Ziegler, R. C. Liddington, and D. R. Critchley, “The structure and regulation of vinculin,” Trends in Cell Biology, vol. 16, no. 9, pp. 453–460, 2006. View at: Publisher Site | Google Scholar
  23. A. Carisey and C. Ballestrem, “Vinculin, an adapter protein in control of cell adhesion signalling,” European Journal of Cell Biology, vol. 90, no. 2-3, pp. 157–163, 2011. View at: Publisher Site | Google Scholar
  24. R. Zaidel-Bar and B. Geiger, “The switchable integrin adhesome,” Journal of Cell Science, vol. 123, no. 9, pp. 1385–1388, 2010. View at: Publisher Site | Google Scholar
  25. K. R. Legate, S. Takahashi, N. Bonakdar et al., “Integrin adhesion and force coupling are independently regulated by localized PtdIns(4,5)2 synthesis,” The EMBO Journal, vol. 30, no. 22, pp. 4539–4553, 2011. View at: Publisher Site | Google Scholar
  26. V. Martel, C. Racaud-Sultan, S. Dupe et al., “Conformation, localization, and integrin binding of talin depend on its interaction with phosphoinositides,” The Journal of Biological Chemistry, vol. 276, no. 24, pp. 21217–21227, 2001. View at: Publisher Site | Google Scholar
  27. A. M. Pasapera, I. C. Schneider, E. Rericha, D. D. Schlaepfer, and C. M. Waterman, “Myosin II activity regulates vinculin recruitment to focal adhesions through FAK-mediated paxillin phosphorylation,” The Journal of Cell Biology, vol. 188, no. 6, pp. 877–890, 2010. View at: Publisher Site | Google Scholar
  28. C. Möhl, N. Kirchgeßner, C. Schäfer et al., “Becoming stable and strong: the interplay between vinculin exchange dynamics and adhesion strength during adhesion site maturation,” Cell Motility and the Cytoskeleton, vol. 66, no. 6, pp. 350–364, 2009. View at: Publisher Site | Google Scholar
  29. C. Margadant, M. Kreft, G. Zambruno, and A. Sonnenberg, “Kindlin-1 regulates integrin dynamics and adhesion turnover,” PLoS One, vol. 8, no. 6, article e65341, 2013. View at: Publisher Site | Google Scholar
  30. M. Régent, E. Planus, A. P. Bouin et al., “Specificities of β1 integrin signaling in the control of cell adhesion and adhesive strength,” European Journal of Cell Biology, vol. 90, no. 2-3, pp. 261–269, 2011. View at: Publisher Site | Google Scholar
  31. P. Bubeck, S. Pistor, J. Wehland, and B. M. Jockusch, “Ligand recruitment by vinculin domains in transfected cells,” Journal of Cell Science, vol. 110, Part 12, pp. 1361–1371, 1997. View at: Google Scholar
  32. C. M. Hampton, D. W. Taylor, and K. A. Taylor, “Novel structures for α-actinin:F-actin interactions and their implications for actin-membrane attachment and tension sensing in the cytoskeleton,” Journal of Molecular Biology, vol. 368, no. 1, pp. 92–104, 2007. View at: Publisher Site | Google Scholar
  33. B. Li and B. Trueb, “Analysis of the α-actinin/zyxin interaction,” Journal of Biological Chemistry, vol. 276, no. 36, pp. 33328–33335, 2001. View at: Publisher Site | Google Scholar
  34. M. Yoshigi, L. M. Hoffman, C. C. Jensen, H. J. Yost, and M. C. Beckerle, “Mechanical force mobilizes zyxin from focal adhesions to actin filaments and regulates cytoskeletal reinforcement,” The Journal of Cell Biology, vol. 171, no. 2, pp. 209–215, 2005. View at: Publisher Site | Google Scholar
  35. A. X. Zhou, J. H. Hartwig, and L. M. Akyurek, “Filamins in cell signaling, transcription and organ development,” Trends in Cell Biology, vol. 20, no. 2, pp. 113–123, 2010. View at: Publisher Site | Google Scholar
  36. Z. Razinia, T. Mäkelä, J. Ylänne, and D. A. Calderwood, “Filamins in mechanosensing and signaling,” Annual Review of Biophysics, vol. 41, no. 1, pp. 227–246, 2012. View at: Publisher Site | Google Scholar
  37. S. Furuike, T. Ito, and M. Yamazaki, “Mechanical unfolding of single filamin A (ABP-280) molecules detected by atomic force microscopy,” FEBS Letters, vol. 498, no. 1, pp. 72–75, 2001. View at: Publisher Site | Google Scholar
  38. M. Yamazaki, S. Furuike, and T. Ito, “Mechanical response of single filamin A (ABP-280) molecules and its role in the actin cytoskeleton,” Journal of Muscle Research and Cell Motility, vol. 23, no. 5/6, pp. 525–534, 2002. View at: Publisher Site | Google Scholar
  39. M. D'Addario, P. D. Arora, R. P. Ellen, and C. A. G. McCulloch, “Interaction of p38 and Sp1 in a mechanical force-induced, β1 integrin-mediated transcriptional circuit that regulates the actin-binding protein filamin-A,” Journal of Biological Chemistry, vol. 277, no. 49, pp. 47541–47550, 2002. View at: Publisher Site | Google Scholar
  40. X. Li and H. S. Earp, “Paxillin is tyrosine-phosphorylated by and preferentially associates with the calcium-dependent tyrosine kinase in rat liver epithelial cells,” The Journal of Biological Chemistry, vol. 272, no. 22, pp. 14341–14348, 1997. View at: Publisher Site | Google Scholar
  41. T. R. Polte and S. K. Hanks, “Interaction between focal adhesion kinase and Crk-associated tyrosine kinase substrate p130Cas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 23, pp. 10678–10682, 1995. View at: Publisher Site | Google Scholar
  42. R. Janoštiak, A. C. Pataki, J. Brábek, and D. Rösel, “Mechanosensors in integrin signaling: the emerging role of p130Cas,” European Journal of Cell Biology, vol. 93, no. 10-12, pp. 445–454, 2014. View at: Publisher Site | Google Scholar
  43. B. J. Mayer, H. Hirai, and R. Sakai, “Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases,” Current Biology, vol. 5, no. 3, pp. 296–305, 1995. View at: Publisher Site | Google Scholar
  44. R. Sakai, A. Iwamatsu, N. Hirano et al., “A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner,” The EMBO Journal, vol. 13, no. 16, pp. 3748–3756, 1994. View at: Publisher Site | Google Scholar
  45. D. D. Schlaepfer, M. A. Broome, and T. Hunter, “Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins,” Molecular and Cellular Biology, vol. 17, no. 3, pp. 1702–1713, 1997. View at: Publisher Site | Google Scholar
  46. P. M. Fonseca, N. Y. Shin, J. Brábek, L. Ryzhova, J. Wu, and S. K. Hanks, “Regulation and localization of CAS substrate domain tyrosine phosphorylation,” Cellular Signalling, vol. 16, no. 5, pp. 621–629, 2004. View at: Publisher Site | Google Scholar
  47. H. Honda, T. Nakamoto, R. Sakai, and H. Hirai, “p130(Cas), an assembling molecule of actin filaments, promotes cell movement, cell migration, and cell spreading in fibroblasts,” Biochemical and Biophysical Research Communications, vol. 262, no. 1, pp. 25–30, 1999. View at: Publisher Site | Google Scholar
  48. E. A. C. Almeida, D. Ilić, Q. Han et al., “Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH2-terminal kinase,” The Journal of Cell Biology, vol. 149, no. 3, pp. 741–754, 2000. View at: Publisher Site | Google Scholar
  49. M. Oktay, K. K. Wary, M. Dans, R. B. Birge, and F. G. Giancotti, “Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle,” Journal of Cell Biology, vol. 145, no. 7, pp. 1461–1470, 1999. View at: Publisher Site | Google Scholar
  50. K. Kawauchi, W. W. Tan, K. Araki et al., “p130Cas-dependent actin remodelling regulates myogenic differentiation,” The Biochemical Journal, vol. 445, no. 3, pp. 323–332, 2012. View at: Publisher Site | Google Scholar
  51. J. K.-H. Hu, W. Du, S. J. Shelton, M. C. Oldham, C. M. DiPersio, and O. D. Klein, “An FAK-YAP-mTOR signaling axis regulates stem cell-based tissue renewal in mice,” Cell Stem Cell, vol. 21, no. 1, pp. 91–106.e6, 2017. View at: Publisher Site | Google Scholar
  52. E. Rozengurt, J. Sinnett-Smith, and G. Eibl, “Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival,” Signal Transduction and Targeted Therapy, vol. 3, no. 1, p. 11, 2018. View at: Publisher Site | Google Scholar
  53. B. Xiang, Y. Liu, W. Zhao, H. Zhao, and H. Yu, “Extracellular calcium regulates the adhesion and migration of osteoclast via integrin αvβ3/ Rho A/cytoskeleton signaling,” Cell Biology International, 2018. View at: Publisher Site | Google Scholar
  54. A. del Rio, R. Perez-Jimenez, R. Liu, P. Roca-Cusachs, J. M. Fernandez, and M. P. Sheetz, “Stretching single talin rod molecules activates vinculin binding,” Science, vol. 323, no. 5914, pp. 638–641, 2009. View at: Publisher Site | Google Scholar
  55. F. Kong, Z. Li, W. M. Parks et al., “Cyclic mechanical reinforcement of integrin-ligand interactions,” Molecular Cell, vol. 49, no. 6, pp. 1060–1068, 2013. View at: Publisher Site | Google Scholar
  56. D. H. Kim, S. B. Khatau, Y. Feng et al., “Actin cap associated focal adhesions and their distinct role in cellular mechanosensing,” Scientific Reports, vol. 2, no. 1, p. 555, 2012. View at: Publisher Site | Google Scholar
  57. R. P. Martins, J. D. Finan, G. Farshid, and D. A. Lee, “Mechanical regulation of nuclear structure and function,” Annual Review of Biomedical Engineering, vol. 14, no. 1, pp. 431–455, 2012. View at: Publisher Site | Google Scholar
  58. I. Solovei, A. S. Wang, K. Thanisch et al., “LBR and lamin A/C sequentially tether peripheral heterochromatin and inversely regulate differentiation,” Cell, vol. 152, no. 3, pp. 584–598, 2013. View at: Publisher Site | Google Scholar
  59. L. J. Barton, A. A. Soshnev, and P. K. Geyer, “Networking in the nucleus: a spotlight on LEM-domain proteins,” Current Opinion in Cell Biology, vol. 34, pp. 1–8, 2015. View at: Publisher Site | Google Scholar
  60. V. P. Lehto, I. Virtanen, and P. Kurki, “Intermediate filaments anchor the nuclei in nuclear monolayers of cultured human fibroblasts,” Nature, vol. 272, no. 5649, pp. 175–177, 1978. View at: Publisher Site | Google Scholar
  61. C. Guilluy, L. D. Osborne, L. van Landeghem et al., “Isolated nuclei adapt to force and reveal a mechanotransduction pathway in the nucleus,” Nature Cell Biology, vol. 16, no. 4, pp. 376–381, 2014. View at: Publisher Site | Google Scholar
  62. D. M. Graham and K. Burridge, “Mechanotransduction and nuclear function,” Current Opinion in Cell Biology, vol. 40, pp. 98–105, 2016. View at: Publisher Site | Google Scholar
  63. D. A. Starr and M. Han, “Role of ANC-1 in tethering nuclei to the actin cytoskeleton,” Science, vol. 298, no. 5592, pp. 406–409, 2002. View at: Publisher Site | Google Scholar
  64. M. Crisp, Q. Liu, K. Roux et al., “Coupling of the nucleus and cytoplasm: role of the LINC complex,” The Journal of Cell Biology, vol. 172, no. 1, pp. 41–53, 2006. View at: Publisher Site | Google Scholar
  65. X. Zhang, K. Lei, X. Yuan et al., “SUN1/2 and Syne/nesprin-1/2 complexes connect centrosome to the nucleus during neurogenesis and neuronal migration in mice,” Neuron, vol. 64, no. 2, pp. 173–187, 2009. View at: Publisher Site | Google Scholar
  66. K. Wilhelmsen, S. H. M. Litjens, I. Kuikman et al., “Nesprin-3, a novel outer nuclear membrane protein, associates with the cytoskeletal linker protein plectin,” The Journal of Cell Biology, vol. 171, no. 5, pp. 799–810, 2005. View at: Publisher Site | Google Scholar
  67. K. J. Roux, M. L. Crisp, Q. Liu et al., “Nesprin 4 is an outer nuclear membrane protein that can induce kinesin-mediated cell polarization,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 7, pp. 2194–2199, 2009. View at: Publisher Site | Google Scholar
  68. N. E. Cain, E. C. Tapley, K. L. McDonald, B. M. Cain, and D. A. Starr, “The SUN protein UNC-84 is required only in force-bearing cells to maintain nuclear envelope architecture,” The Journal of Cell Biology, vol. 206, no. 2, pp. 163–172, 2014. View at: Publisher Site | Google Scholar
  69. S. Blone, K. Small, V. M. A. Aksmanovic et al., “Identification of new mutations in the Emery-Dreifuss muscular dystrophy gene and evidence for genetic heterogeneity of the disease,” Human Molecular Genetics, vol. 4, no. 10, pp. 1859–1863, 1995. View at: Publisher Site | Google Scholar
  70. J. Lammerding, J. Hsiao, P. C. Schulze, S. Kozlov, C. L. Stewart, and R. T. Lee, “Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells,” The Journal of Cell Biology, vol. 170, no. 5, pp. 781–791, 2005. View at: Publisher Site | Google Scholar
  71. B. D. Matthews, D. R. Overby, R. Mannix, and D. E. Ingber, “Cellular adaptation to mechanical stress: role of integrins, Rho, cytoskeletal tension and mechanosensitive ion channels,” Journal of Cell Science, vol. 119, no. 3, pp. 508–518, 2006. View at: Publisher Site | Google Scholar
  72. K. Hayakawa, H. Tatsumi, and M. Sokabe, “Actin stress fibers transmit and focus force to activate mechanosensitive channels,” Journal of Cell Science, vol. 121, no. 4, pp. 496–503, 2008. View at: Publisher Site | Google Scholar
  73. K. A. DeMali, K. Wennerberg, and K. Burridge, “Integrin signaling to the actin cytoskeleton,” Current Opinion in Cell Biology, vol. 15, no. 5, pp. 572–582, 2003. View at: Publisher Site | Google Scholar
  74. A. J. Putnam, J. J. Cunningham, B. B. L. Pillemer, and D. J. Mooney, “External mechanical strain regulates membrane targeting of Rho GTPases by controlling microtubule assembly,” American Journal of Physiology. Cell Physiology, vol. 284, no. 3, pp. C627–C639, 2003. View at: Publisher Site | Google Scholar
  75. T. Ishida, M. Takahashi, M. A. Corson, and B. C. Berk, “Fluid shear stress-mediated signal transduction: how do endothelial cells transduce mechanical force into biological responses?” Annals of the New York Academy of Sciences, vol. 811, pp. 12–24, 1997. View at: Publisher Site | Google Scholar
  76. S. Lehoux, Y. Castier, and A. Tedgui, “Molecular mechanisms of the vascular responses to haemodynamic forces,” Journal of Internal Medicine, vol. 259, no. 4, pp. 381–392, 2006. View at: Publisher Site | Google Scholar
  77. T. Ishida, T. E. Peterson, N. L. Kovach, and B. C. Berk, “MAP kinase activation by flow in endothelial cells. Role of β1 integrins and tyrosine kinases,” Circulation Research, vol. 79, no. 2, pp. 310–316, 1996. View at: Publisher Site | Google Scholar
  78. C. Schmidt, H. Pommerenke, F. Dürr, B. Nebe, and J. Rychly, “Mechanical stressing of integrin receptors induces enhanced tyrosine phosphorylation of cytoskeletally anchored proteins,” Journal of Biological Chemistry, vol. 273, no. 9, pp. 5081–5085, 1998. View at: Publisher Site | Google Scholar
  79. J. L. Schwachtgen, P. Houston, C. Campbell, V. Sukhatme, and M. Braddock, “Fluid shear stress activation of egr-1 transcription in cultured human endothelial and epithelial cells is mediated via the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway,” The Journal of Clinical Investigation, vol. 101, no. 11, pp. 2540–2549, 1998. View at: Publisher Site | Google Scholar
  80. Y. Sawada, M. Tamada, B. J. Dubin-Thaler et al., “Force sensing by mechanical extension of the Src family kinase substrate p130Cas,” Cell, vol. 127, no. 5, pp. 1015–1026, 2006. View at: Publisher Site | Google Scholar
  81. M. Tamada, M. P. Sheetz, and Y. Sawada, “Activation of a signaling cascade by cytoskeleton stretch,” Developmental Cell, vol. 7, no. 5, pp. 709–718, 2004. View at: Publisher Site | Google Scholar
  82. K. Burridge and K. Wennerberg, “Rho and Rac take center stage,” Cell, vol. 116, no. 2, pp. 167–179, 2004. View at: Publisher Site | Google Scholar
  83. A. B. Jaffe and A. Hall, “Rho GTPases: biochemistry and biology,” Annual Review of Cell and Developmental Biology, vol. 21, no. 1, pp. 247–269, 2005. View at: Publisher Site | Google Scholar
  84. E. C. Lessey, C. Guilluy, and K. Burridge, “From mechanical force to RhoA activation,” Biochemistry, vol. 51, no. 38, pp. 7420–7432, 2012. View at: Publisher Site | Google Scholar
  85. V. Vogel and M. Sheetz, “Local force and geometry sensing regulate cell functions,” Nature Reviews Molecular Cell Biology, vol. 7, no. 4, pp. 265–275, 2006. View at: Publisher Site | Google Scholar
  86. K. G. Young and J. W. Copeland, “Formins in cell signaling,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1803, no. 2, pp. 183–190, 2010. View at: Publisher Site | Google Scholar
  87. G. Civelekoglu-Scholey, A. Wayne Orr, I. Novak, J. J. Meister, M. A. Schwartz, and A. Mogilner, “Model of coupled transient changes of Rac, Rho, adhesions and stress fibers alignment in endothelial cells responding to shear stress,” Journal of Theoretical Biology, vol. 232, no. 4, pp. 569–585, 2005. View at: Publisher Site | Google Scholar
  88. D. Zhou, D. J. Herrick, J. Rosenbloom, and B. Chaqour, “Cyr61 mediates the expression of VEGF, αv-integrin, and α-actin genes through cytoskeletally based mechanotransduction mechanisms in bladder smooth muscle cells,” Journal of Applied Physiology, vol. 98, no. 6, pp. 2344–2354, 2005. View at: Publisher Site | Google Scholar
  89. A. Sarasa-Renedo, V. Tunc-Civelek, and M. Chiquet, “Role of RhoA/ROCK-dependent actin contractility in the induction of tenascin-C by cyclic tensile strain,” Experimental Cell Research, vol. 312, no. 8, pp. 1361–1370, 2006. View at: Publisher Site | Google Scholar
  90. E. Tzima, W. B. Kiosses, M. A. del Pozo, and M. A. Schwartz, “Localized cdc42 activation, detected using a novel assay, mediates microtubule organizing center positioning in endothelial cells in response to fluid shear stress,” Journal of Biological Chemistry, vol. 278, no. 33, pp. 31020–31023, 2003. View at: Publisher Site | Google Scholar
  91. X. H. Zhao, C. Laschinger, P. Arora, K. Szaszi, A. Kapus, and C. A. McCulloch, “Force activates smooth muscle α-actin promoter activity through the Rho signaling pathway,” Journal of Cell Science, vol. 120, no. 10, pp. 1801–1809, 2007. View at: Publisher Site | Google Scholar
  92. M. B. Asparuhova, L. Gelman, and M. Chiquet, “Role of the actin cytoskeleton in tuning cellular responses to external mechanical stress,” Scandinavian Journal of Medicine & Science in Sports, vol. 19, no. 4, pp. 490–499, 2009. View at: Publisher Site | Google Scholar
  93. R. Zaidel-Bar, C. Ballestrem, Z. Kam, and B. Geiger, “Early molecular events in the assembly of matrix adhesions at the leading edge of migrating cells,” Journal of Cell Science, vol. 116, no. 22, pp. 4605–4613, 2003. View at: Publisher Site | Google Scholar
  94. S. K. Hanks, L. Ryzhova, N. Y. Shin, and J. Brábek, “Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility,” Frontiers in Bioscience, vol. 8, no. 4, pp. d982–d996, 2003. View at: Publisher Site | Google Scholar
  95. Y. Nojima, N. Morino, T. Mimura et al., “Integrin-mediated cell adhesion promotes tyrosine phosphorylation of p130Cas, a Src homology 3-containing molecule having multiple Src homology 2-binding motifs,” Journal of Biological Chemistry, vol. 270, no. 25, pp. 15398–15402, 1995. View at: Publisher Site | Google Scholar
  96. T. S. Panetti, “Tyrosine phosphorylation of paxillin, FAK, and p130CAS: effects on cell spreading and migration,” Frontiers in Bioscience, vol. 7, pp. d143–d150, 2002. View at: Google Scholar
  97. H. B. Schiller, M. R. Hermann, J. Polleux et al., “β1- and αv-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments,” Nature Cell Biology, vol. 15, no. 6, pp. 625–636, 2013. View at: Publisher Site | Google Scholar
  98. L. Vitillo and S. J. Kimber, “Integrin and FAK regulation of human pluripotent stem cells,” Current Stem Cell Reports, vol. 3, no. 4, pp. 358–365, 2017. View at: Publisher Site | Google Scholar
  99. M. Ohgushi, M. Matsumura, M. Eiraku et al., “Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells,” Cell Stem Cell, vol. 7, no. 2, pp. 225–239, 2010. View at: Publisher Site | Google Scholar
  100. M. A. Baxter, M. V. Camarasa, N. Bates et al., “Analysis of the distinct functions of growth factors and tissue culture substrates necessary for the long-term self-renewal of human embryonic stem cell lines,” Stem Cell Research, vol. 3, no. 1, pp. 28–38, 2009. View at: Publisher Site | Google Scholar
  101. D. Soteriou, B. Iskender, A. Byron et al., “Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance,” The Journal of Biological Chemistry, vol. 288, no. 26, pp. 18716–18731, 2013. View at: Publisher Site | Google Scholar
  102. J. Rajagopal and B. Z. Stanger, “Plasticity in the adult: how should the Waddington diagram be applied to regenerating tissues?” Developmental Cell, vol. 36, no. 2, pp. 133–137, 2016. View at: Publisher Site | Google Scholar
  103. C. H. Waddington, The Strategy of the Genes: A Discussion of some Aspects of Theoretical Biology, George Allen & Unwin Ltd, London, 1957.
  104. J. M. W. Slack, “Conrad Hal Waddington: the last renaissance biologist?” Nature Reviews Genetics, vol. 3, no. 11, pp. 889–895, 2002. View at: Publisher Site | Google Scholar
  105. B. Ebrahimi, “Reprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotency,” Cell Regeneration, vol. 4, no. 1, p. 10, 2015. View at: Publisher Site | Google Scholar
  106. P. Samavarchi-Tehrani, A. Golipour, L. David et al., “Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming,” Cell Stem Cell, vol. 7, no. 1, pp. 64–77, 2010. View at: Publisher Site | Google Scholar
  107. L. Warren, P. D. Manos, T. Ahfeldt et al., “Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA,” Cell Stem Cell, vol. 7, no. 5, pp. 618–630, 2010. View at: Publisher Site | Google Scholar
  108. Z. Li and T. M. Rana, “A kinase inhibitor screen identifies small-molecule enhancers of reprogramming and iPS cell generation,” Nature Communications, vol. 3, no. 1, p. 1085, 2012. View at: Publisher Site | Google Scholar
  109. B. Feng, J. H. Ng, J. C. D. Heng, and H. H. Ng, “Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells,” Cell Stem Cell, vol. 4, no. 4, pp. 301–312, 2009. View at: Publisher Site | Google Scholar
  110. N. Miyoshi, H. Ishii, H. Nagano et al., “Reprogramming of mouse and human cells to pluripotency using mature microRNAs,” Cell Stem Cell, vol. 8, no. 6, pp. 633–638, 2011. View at: Publisher Site | Google Scholar
  111. M. J. Dalby, N. Gadegaard, and R. O. C. Oreffo, “Harnessing nanotopography and integrin-matrix interactions to influence stem cell fate,” Nature Materials, vol. 13, no. 6, pp. 558–569, 2014. View at: Publisher Site | Google Scholar
  112. T. L. Downing, J. Soto, C. Morez et al., “Biophysical regulation of epigenetic state and cell reprogramming,” Nature Materials, vol. 12, no. 12, pp. 1154–1162, 2013. View at: Publisher Site | Google Scholar
  113. Y. M. Kim, Y. G. Kang, S. H. Park et al., “Effects of mechanical stimulation on the reprogramming of somatic cells into human-induced pluripotent stem cells,” Stem Cell Research & Therapy, vol. 8, no. 1, p. 139, 2017. View at: Publisher Site | Google Scholar
  114. D. Li, J. Zhou, L. Wang et al., “Integrated biochemical and mechanical signals regulate multifaceted human embryonic stem cell functions,” The Journal of Cell Biology, vol. 191, no. 3, pp. 631–644, 2010. View at: Publisher Site | Google Scholar
  115. Y. C. Toh, J. Xing, and H. Yu, “Modulation of integrin and E-cadherin-mediated adhesions to spatially control heterogeneity in human pluripotent stem cell differentiation,” Biomaterials, vol. 50, pp. 87–97, 2015. View at: Publisher Site | Google Scholar
  116. S. Abbasalizadeh, M. R. Larijani, A. Samadian, and H. Baharvand, “Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor,” Tissue Engineering Part C: Methods, vol. 18, no. 11, pp. 831–851, 2012. View at: Publisher Site | Google Scholar
  117. C. Kropp, H. Kempf, C. Halloin et al., “Impact of feeding strategies on the scalable expansion of human pluripotent stem cells in single-use stirred tank bioreactors,” Stem Cells Translational Medicine, vol. 5, no. 10, pp. 1289–1301, 2016. View at: Publisher Site | Google Scholar
  118. J. Beers, D. R. Gulbranson, N. George et al., “Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions,” Nature Protocols, vol. 7, no. 11, pp. 2029–2040, 2012. View at: Publisher Site | Google Scholar
  119. G. Chen, Z. Hou, D. R. Gulbranson, and J. A. Thomson, “Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells,” Cell Stem Cell, vol. 7, no. 2, pp. 240–248, 2010. View at: Publisher Site | Google Scholar
  120. S. Kilens, D. Meistermann, D. Moreno et al., “Parallel derivation of isogenic human primed and naive induced pluripotent stem cells,” Nature Communications, vol. 9, no. 1, p. 360, 2018. View at: Publisher Site | Google Scholar
  121. J. Nichols and A. Smith, “Naive and primed pluripotent states,” Cell Stem Cell, vol. 4, no. 6, pp. 487–492, 2009. View at: Publisher Site | Google Scholar
  122. I. G. M. Brons, L. E. Smithers, M. W. B. Trotter et al., “Derivation of pluripotent epiblast stem cells from mammalian embryos,” Nature, vol. 448, no. 7150, pp. 191–195, 2007. View at: Publisher Site | Google Scholar
  123. P. J. Tesar, J. G. Chenoweth, F. A. Brook et al., “New cell lines from mouse epiblast share defining features with human embryonic stem cells,” Nature, vol. 448, no. 7150, pp. 196–199, 2007. View at: Publisher Site | Google Scholar
  124. Y. Yang, B. Liu, J. Xu et al., “Derivation of pluripotent stem cells with in vivo embryonic and extraembryonic potency,” Cell, vol. 169, no. 2, pp. 243–257.e25, 2017. View at: Publisher Site | Google Scholar
  125. H. Chen, I. Aksoy, F. Gonnot et al., “Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency,” Nature Communications, vol. 6, no. 1, p. 7095, 2015. View at: Publisher Site | Google Scholar
  126. Y. S. Chan, J. Göke, J. H. Ng et al., “Induction of a human pluripotent state with distinct regulatory circuitry that resembles preimplantation epiblast,” Cell Stem Cell, vol. 13, no. 6, pp. 663–675, 2013. View at: Publisher Site | Google Scholar
  127. O. Gafni, L. Weinberger, A. A. Mansour et al., “Derivation of novel human ground state naive pluripotent stem cells,” Nature, vol. 504, no. 7479, pp. 282–286, 2013. View at: Publisher Site | Google Scholar
  128. Y. Takashima, G. Guo, R. Loos et al., “Resetting transcription factor control circuitry toward ground-state pluripotency in human,” Cell, vol. 158, no. 6, pp. 1254–1269, 2014. View at: Publisher Site | Google Scholar
  129. T. W. Theunissen, B. E. Powell, H. Wang et al., “Systematic identification of culture conditions for induction and maintenance of naive human pluripotency,” Cell Stem Cell, vol. 15, no. 4, pp. 471–487, 2014. View at: Publisher Site | Google Scholar
  130. Y. Hayashi and M. K. Furue, “Biological effects of culture substrates on human pluripotent stem cells,” Stem Cells International, vol. 2016, Article ID 5380560, 11 pages, 2016. View at: Publisher Site | Google Scholar
  131. Y. Hayashi, M. K. Furue, T. Okamoto et al., “Integrins regulate mouse embryonic stem cell self-renewal,” Stem Cells, vol. 25, no. 12, pp. 3005–3015, 2007. View at: Publisher Site | Google Scholar
  132. T. J. Rowland, L. M. Miller, A. J. Blaschke et al., “Roles of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin,” Stem Cells and Development, vol. 19, no. 8, pp. 1231–1240, 2010. View at: Publisher Site | Google Scholar
  133. T. Yu, S. Miyagawa, K. Miki et al., “In vivo differentiation of induced pluripotent stem cell-derived cardiomyocytes,” Circulation Journal, vol. 77, no. 5, pp. 1297–1306, 2013. View at: Publisher Site | Google Scholar
  134. H. Y. Kim, S. Baek, N. R. Han, E. Lee, C. K. Park, and S. T. Lee, “Identification of integrin heterodimers functioning on the surface of undifferentiated porcine primed embryonic stem cells,” Cell Biology International, vol. 42, no. 9, pp. 1221–1227, 2018. View at: Publisher Site | Google Scholar
  135. Y. Meng, S. Eshghi, Y. J. Li, R. Schmidt, D. V. Schaffer, and K. E. Healy, “Characterization of integrin engagement during defined human embryonic stem cell culture,” The FASEB Journal, vol. 24, no. 4, pp. 1056–1065, 2010. View at: Publisher Site | Google Scholar
  136. S. T. Lee, J. I. Yun, Y. S. Jo et al., “Engineering integrin signaling for promoting embryonic stem cell self-renewal in a precisely defined niche,” Biomaterials, vol. 31, no. 6, pp. 1219–1226, 2010. View at: Publisher Site | Google Scholar
  137. L. G. Villa-Diaz, J. K. Kim, A. Laperle, S. P. Palecek, and P. H. Krebsbach, “Inhibition of focal adhesion kinase signaling by integrin α6β1 supports human pluripotent stem cell self-renewal,” Stem Cells, vol. 34, no. 7, pp. 1753–1764, 2016. View at: Publisher Site | Google Scholar
  138. O. Hazenbiller, N. A. Duncan, and R. J. Krawetz, “Reduction of pluripotent gene expression in murine embryonic stem cells exposed to mechanical loading or Cyclo RGD peptide,” BMC Cell Biology, vol. 18, no. 1, p. 32, 2017. View at: Publisher Site | Google Scholar
  139. T. Miyazaki, S. Futaki, K. Hasegawa et al., “Recombinant human laminin isoforms can support the undifferentiated growth of human embryonic stem cells,” Biochemical and Biophysical Research Communications, vol. 375, no. 1, pp. 27–32, 2008. View at: Publisher Site | Google Scholar
  140. C. L. Mummery, J. Zhang, E. S. Ng, D. A. Elliott, A. G. Elefanty, and T. J. Kamp, “Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview,” Circulation Research, vol. 111, no. 3, pp. 344–358, 2012. View at: Publisher Site | Google Scholar
  141. D. Zeng, D. B. Ou, T. Wei et al., “Collagen/β1 integrin interaction is required for embryoid body formation during cardiogenesis from murine induced pluripotent stem cells,” BMC Cell Biology, vol. 14, no. 1, p. 5, 2013. View at: Publisher Site | Google Scholar
  142. H. C. Moeller, M. K. Mian, S. Shrivastava, B. G. Chung, and A. Khademhosseini, “A microwell array system for stem cell culture,” Biomaterials, vol. 29, no. 6, pp. 752–763, 2008. View at: Publisher Site | Google Scholar
  143. B. Valamehr, S. J. Jonas, J. Polleux et al., “Hydrophobic surfaces for enhanced differentiation of embryonic stem cell-derived embryoid bodies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 38, pp. 14459–14464, 2008. View at: Publisher Site | Google Scholar
  144. Y. S. Hwang, B. G. Chung, D. Ortmann, N. Hattori, H. C. Moeller, and A. Khademhosseini, “Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 40, pp. 16978–16983, 2009. View at: Publisher Site | Google Scholar
  145. X. Lian, J. Zhang, S. M. Azarin et al., “Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions,” Nature Protocols, vol. 8, no. 1, pp. 162–175, 2013. View at: Publisher Site | Google Scholar
  146. S. Bhattacharya, P. W. Burridge, E. M. Kropp et al., “High efficiency differentiation of human pluripotent stem cells to cardiomyocytes and characterization by flow cytometry,” Journal of Visualized Experiments, vol. 91, no. 91, article 52010, 2014. View at: Publisher Site | Google Scholar
  147. P. W. Burridge, S. Thompson, M. A. Millrod et al., “A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability,” PLoS One, vol. 6, no. 4, article e18293, 2011. View at: Publisher Site | Google Scholar
  148. R. G. James, W. H. Conrad, and R. T. Moon, “β-Catenin-independent Wnt pathways: signals, core proteins, and effectors,” Methods in Molecular Biology, vol. 468, pp. 131–144, 2008. View at: Publisher Site | Google Scholar
  149. D. Kumar, S. Sharma, S. Verma, P. Kumar, and R. K. Ambasta, “Role of Wnt-p53-Nox signaling pathway in cancer development and progression,” British Journal of Medicine and Medical Research, vol. 8, no. 8, pp. 651–676, 2015. View at: Publisher Site | Google Scholar
  150. T. S. Huang, L. Li, L. Moalim-Nour et al., “A regulatory network involving β-catenin, e-cadherin, PI3k/Akt, and SLUG balances self-renewal and differentiation of human pluripotent stem cells in response to Wnt signaling,” Stem Cells, vol. 33, no. 5, pp. 1419–1433, 2015. View at: Publisher Site | Google Scholar
  151. M. Zhao, C. Fan, P. J. Ernst et al., “Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice,” Cardiovascular Research, vol. 115, no. 2, pp. 343–356, 2019. View at: Publisher Site | Google Scholar
  152. A. Kallas-Kivi, A. Trei, A. Stepanjuk et al., “The role of integrin β1 in the heterogeneity of human embryonic stem cells culture,” Biology Open, vol. 7, no. 11, article bio034355, 2018. View at: Publisher Site | Google Scholar
  153. N. Gadhari, M. Charnley, M. Marelli, J. Brugger, and M. Chiquet, “Cell shape-dependent early responses of fibroblasts to cyclic strain,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1833, no. 12, pp. 3415–3425, 2013. View at: Publisher Site | Google Scholar
  154. G. Posern and R. Treisman, “Actin’ together: serum response factor, its cofactors and the link to signal transduction,” Trends in Cell Biology, vol. 16, no. 11, pp. 588–596, 2006. View at: Publisher Site | Google Scholar
  155. T. Kishi, T. Mayanagi, S. Iwabuchi, T. Akasaka, and K. Sobue, “Myocardin-related transcription factor A (MRTF-A) activity-dependent cell adhesion is correlated to focal adhesion kinase (FAK) activity,” Oncotarget, vol. 7, no. 44, pp. 72113–72130, 2016. View at: Publisher Site | Google Scholar
  156. G. Galmiche, C. Labat, M. Mericskay et al., “Inactivation of serum response factor contributes to decrease vascular muscular tone and arterial stiffness in mice,” Circulation Research, vol. 112, no. 7, pp. 1035–1045, 2013. View at: Publisher Site | Google Scholar
  157. L. Wei, L. Wang, J. A. Carson, J. E. Agan, K. Imanaka-Yoshida, and R. J. Schwartz, “β1 integrin and organized actin filaments facilitate cardiomyocyte-specific RhoA-dependent activation of the skeletal α-actin promoter,” The FASEB Journal, vol. 15, no. 3, pp. 785–796, 2001. View at: Publisher Site | Google Scholar
  158. G. Schratt, U. Philippar, J. Berger, H. Schwarz, O. Heidenreich, and A. Nordheim, “Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cells,” The Journal of Cell Biology, vol. 156, no. 4, pp. 737–750, 2002. View at: Publisher Site | Google Scholar
  159. S. Dupont, L. Morsut, M. Aragona et al., “Role of YAP/TAZ in mechanotransduction,” Nature, vol. 474, no. 7350, pp. 179–183, 2011. View at: Publisher Site | Google Scholar
  160. M. Pesce and R. Santoro, “Feeling the right force: how to contextualize the cell mechanical behavior in physiologic turnover and pathologic evolution of the cardiovascular system,” Pharmacology & Therapeutics, vol. 171, pp. 75–82, 2017. View at: Publisher Site | Google Scholar
  161. G. Nardone, J. Oliver-de la Cruz, J. Vrbsky et al., “YAP regulates cell mechanics by controlling focal adhesion assembly,” Nature Communications, vol. 8, article 15321, 2017. View at: Publisher Site | Google Scholar
  162. S. Dupont, “Role of YAP/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction,” Experimental Cell Research, vol. 343, no. 1, pp. 42–53, 2016. View at: Publisher Site | Google Scholar
  163. J. S. Mo, F. X. Yu, R. Gong, J. H. Brown, and K. L. Guan, “Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs),” Genes & Development, vol. 26, no. 19, pp. 2138–2143, 2012. View at: Publisher Site | Google Scholar
  164. R. Santoro, D. Scaini, L. U. Severino et al., “Activation of human aortic valve interstitial cells by local stiffness involves YAP-dependent transcriptional signaling,” Biomaterials, vol. 181, pp. 268–279, 2018. View at: Publisher Site | Google Scholar
  165. R. McBeath, D. M. Pirone, C. M. Nelson, K. Bhadriraju, and C. S. Chen, “Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment,” Developmental Cell, vol. 6, no. 4, pp. 483–495, 2004. View at: Publisher Site | Google Scholar
  166. A. Elbediwy and B. J. Thompson, “Evolution of mechanotransduction via YAP/TAZ in animal epithelia,” Current Opinion in Cell Biology, vol. 51, pp. 117–123, 2018. View at: Publisher Site | Google Scholar
  167. H. Sabra, M. Brunner, V. Mandati et al., “β1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin,” The Journal of Biological Chemistry, vol. 292, no. 47, pp. 19179–19197, 2017. View at: Publisher Site | Google Scholar
  168. F. Gattazzo, A. Urciuolo, and P. Bonaldo, “Extracellular matrix: a dynamic microenvironment for stem cell niche,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1840, no. 8, pp. 2506–2519, 2014. View at: Publisher Site | Google Scholar
  169. T. Rozario and D. W. DeSimone, “The extracellular matrix in development and morphogenesis: a dynamic view,” Developmental Biology, vol. 341, no. 1, pp. 126–140, 2010. View at: Publisher Site | Google Scholar
  170. R. Santoro, F. Consolo, M. Spiccia et al., “Feasibility of pig and human-derived aortic valve interstitial cells seeding on fixative-free decellularized animal pericardium,” Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 104, no. 2, pp. 345–356, 2016. View at: Publisher Site | Google Scholar
  171. K. Narayanan, V. Y. Lim, J. Shen et al., “Extracellular matrix-mediated differentiation of human embryonic stem cells: differentiation to insulin-secreting beta cells,” Tissue Engineering Part A, vol. 20, no. 1-2, pp. 424–433, 2014. View at: Publisher Site | Google Scholar
  172. B. Liau, N. Christoforou, K. W. Leong, and N. Bursac, “Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function,” Biomaterials, vol. 32, no. 35, pp. 9180–9187, 2011. View at: Publisher Site | Google Scholar
  173. F. Moroni and T. Mirabella, “Decellularized matrices for cardiovascular tissue engineering,” American Journal of Stem Cells, vol. 3, no. 1, pp. 1–20, 2014. View at: Google Scholar
  174. K. P. Robb, A. Shridhar, and L. E. Flynn, “Decellularized matrices as cell-instructive scaffolds to guide tissue-specific regeneration,” ACS Biomaterials Science & Engineering, vol. 4, no. 11, pp. 3627–3643, 2018. View at: Publisher Site | Google Scholar
  175. E. Garreta, L. de Oñate, M. E. Fernández-Santos et al., “Myocardial commitment from human pluripotent stem cells: rapid production of human heart grafts,” Biomaterials, vol. 98, pp. 64–78, 2016. View at: Publisher Site | Google Scholar
  176. P. L. Sánchez, M. E. Fernández-Santos, S. Costanza et al., “Acellular human heart matrix: a critical step toward whole heart grafts,” Biomaterials, vol. 61, pp. 279–289, 2015. View at: Publisher Site | Google Scholar
  177. J. P. Guyette, J. M. Charest, R. W. Mills et al., “Bioengineering human myocardium on native extracellular matrix,” Circulation Research, vol. 118, no. 1, pp. 56–72, 2016. View at: Publisher Site | Google Scholar
  178. W. L. Stoppel, A. E. Gao, A. M. Greaney et al., “Elastic, silk-cardiac extracellular matrix hydrogels exhibit time-dependent stiffening that modulates cardiac fibroblast response,” Journal of Biomedical Materials Research Part A, vol. 104, no. 12, pp. 3058–3072, 2016. View at: Publisher Site | Google Scholar
  179. F. Amadeo, F. Boschetti, G. Polvani, C. Banfi, M. Pesce, and R. Santoro, “Aortic valve cell seeding into decellularized animal pericardium by perfusion-assisted bioreactor,” Journal of Tissue Engineering and Regenerative Medicine, vol. 12, no. 6, pp. 1481–1493, 2018. View at: Publisher Site | Google Scholar
  180. D. A. Taylor, O. H. Frazier, A. Elgalad, C. Hochman-Mendez, and L. C. Sampaio, “Building a total bioartificial heart: harnessing nature to overcome the current hurdles,” Artif Organs, vol. 42, no. 10, pp. 970–982, 2018. View at: Publisher Site | Google Scholar
  181. S. Yesmin, M. B. Paget, H. E. Murray, and R. Downing, “Bio-scaffolds in organ-regeneration: clinical potential and current challenges,” Current Research in Translational Medicine, vol. 65, no. 3, pp. 103–113, 2017. View at: Publisher Site | Google Scholar
  182. F. Pati, J. Jang, D. H. Ha et al., “Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink,” Nature Communications, vol. 5, no. 1, article 3935, 2014. View at: Publisher Site | Google Scholar
  183. X. Ma, C. Yu, P. Wang et al., “Rapid 3D bioprinting of decellularized extracellular matrix with regionally varied mechanical properties and biomimetic microarchitecture,” Biomaterials, vol. 185, pp. 310–321, 2018. View at: Publisher Site | Google Scholar
  184. A. Moorthi, Y. C. Tyan, and T. W. Chung, “Surface-modified polymers for cardiac tissue engineering,” Biomaterials Science, vol. 5, no. 10, pp. 1976–1987, 2017. View at: Publisher Site | Google Scholar
  185. H. Kasahara and I. Hayashi, “Polyglycolic acid sheet with fibrin glue potentiates the effect of a fibrin-based haemostat in cardiac surgery,” Journal of Cardiothoracic Surgery, vol. 9, no. 1, p. 121, 2014. View at: Publisher Site | Google Scholar
  186. V. Chiono, P. Mozetic, M. Boffito et al., “Polyurethane-based scaffolds for myocardial tissue engineering,” Interface Focus, vol. 4, no. 1, article 20130045, 2014. View at: Publisher Site | Google Scholar
  187. M. Boffito, F. di Meglio, P. Mozetic et al., “Surface functionalization of polyurethane scaffolds mimicking the myocardial microenvironment to support cardiac primitive cells,” PLoS One, vol. 13, no. 7, article e0199896, 2018. View at: Publisher Site | Google Scholar
  188. M. H. Yang, S. B. Jong, C. Y. Lu et al., “Assessing the responses of cellular proteins induced by hyaluronic acid-modified surfaces utilizing a mass spectrometry-based profiling system: over-expression of CD36, CD44, CDK9, and PP2A,” Analyst, vol. 137, no. 21, pp. 4921–4933, 2012. View at: Publisher Site | Google Scholar
  189. F. Vozzi, F. Logrand, M. Cabiati et al., “Biomimetic engineering of the cardiac tissue through processing, functionalization, and biological characterization of polyester urethanes,” Biomedical Materials, vol. 13, no. 5, p. 055006, 2018. View at: Publisher Site | Google Scholar
  190. J. Yang, Y. Mei, A. L. Hook et al., “Polymer surface functionalities that control human embryoid body cell adhesion revealed by high throughput surface characterization of combinatorial material microarrays,” Biomaterials, vol. 31, no. 34, pp. 8827–8838, 2010. View at: Publisher Site | Google Scholar
  191. W. H. Zimmermann, I. Melnychenko, and T. Eschenhagen, “Engineered heart tissue for regeneration of diseased hearts,” Biomaterials, vol. 25, no. 9, pp. 1639–1647, 2004. View at: Publisher Site | Google Scholar
  192. C. Castaldo, F. di Meglio, R. Miraglia et al., “Cardiac fibroblast-derived extracellular matrix (biomatrix) as a model for the studies of cardiac primitive cell biological properties in normal and pathological adult human heart,” BioMed Research International, vol. 2013, Article ID 352370, 7 pages, 2013. View at: Publisher Site | Google Scholar
  193. R. V. Nair, A. Farrukh, and A. Del Campo, “A photoactivatable α5β1-specific integrin ligand,” Chembiochem, vol. 19, no. 12, pp. 1280–1287, 2018. View at: Publisher Site | Google Scholar
  194. S. Y. Boateng, S. S. Lateef, W. Mosley, T. J. Hartman, L. Hanley, and B. Russell, “RGD and YIGSR synthetic peptides facilitate cellular adhesion identical to that of laminin and fibronectin but alter the physiology of neonatal cardiac myocytes,” American Journal of Physiology Cell Physiology, vol. 288, no. 1, pp. C30–C38, 2005. View at: Publisher Site | Google Scholar
  195. S. Mukherjee, J. Reddy Venugopal, R. Ravichandran, S. Ramakrishna, and M. Raghunath, “Evaluation of the biocompatibility of PLACL/collagen nanostructured matrices with cardiomyocytes as a model for the regeneration of infarcted myocardium,” Advanced Functional Materials, vol. 21, no. 12, pp. 2291–2300, 2011. View at: Publisher Site | Google Scholar
  196. D. A. Wang, J. Ji, Y. H. Sun, J. C. Shen, L. X. Feng, and J. H. Elisseeff, “In situ immobilization of proteins and RGD peptide on polyurethane surfaces via poly(ethylene oxide) coupling polymers for human endothelial cell growth,” Biomacromolecules, vol. 3, no. 6, pp. 1286–1295, 2002. View at: Publisher Site | Google Scholar
  197. M. Riaz, M. Versaevel, D. Mohammed, K. Glinel, and S. Gabriele, “Persistence of fan-shaped keratocytes is a matrix-rigidity-dependent mechanism that requires α5β1 integrin engagement,” Scientific Reports, vol. 6, no. 1, p. 34141, 2016. View at: Publisher Site | Google Scholar
  198. E. M. Ovadia, D. W. Colby, and A. M. Kloxin, “Designing well-defined photopolymerized synthetic matrices for three-dimensional culture and differentiation of induced pluripotent stem cells,” Biomaterials Science, vol. 6, no. 6, pp. 1358–1370, 2018. View at: Publisher Site | Google Scholar
  199. C. K. K. Choi, Y. J. Xu, B. Wang, M. Zhu, L. Zhang, and L. Bian, “Substrate coupling strength of integrin-binding ligands modulates adhesion, spreading, and differentiation of human mesenchymal stem cells,” Nano Letters, vol. 15, no. 10, pp. 6592–6600, 2015. View at: Publisher Site | Google Scholar
  200. W. S. Chen, L. Y. Guo, A. M. Masroujeh et al., “A single-step surface modification of electrospun silica nanofibers using a silica binding protein fused with an RGD motif for enhanced PC12 cell growth and differentiation,” Materials, vol. 11, no. 6, 2018. View at: Publisher Site | Google Scholar
  201. C. C. Cheng, D. J. Lee, and J. K. Chen, “Self-assembled supramolecular polymers with tailorable properties that enhance cell attachment and proliferation,” Acta Biomaterialia, vol. 50, pp. 476–483, 2017. View at: Publisher Site | Google Scholar
  202. Y. W. Chun, D. A. Balikov, T. K. Feaster et al., “Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes,” Biomaterials, vol. 67, pp. 52–64, 2015. View at: Publisher Site | Google Scholar
  203. E. Grespan, G. G. Giobbe, F. Badique, K. Anselme, J. Rühe, and N. Elvassore, “Effect of geometrical constraints on human pluripotent stem cell nuclei in pluripotency and differentiation,” Integrative Biology, vol. 10, no. 5, pp. 278–289, 2018. View at: Publisher Site | Google Scholar
  204. H. R. Seo, H. J. Joo, D. H. Kim et al., “Nanopillar surface topology promotes cardiomyocyte differentiation through cofilin-mediated cytoskeleton rearrangement,” ACS Applied Materials & Interfaces, vol. 9, no. 20, pp. 16803–16812, 2017. View at: Publisher Site | Google Scholar
  205. E. Cimetta, S. Pizzato, S. Bollini, E. Serena, P. de Coppi, and N. Elvassore, “Production of arrays of cardiac and skeletal muscle myofibers by micropatterning techniques on a soft substrate,” Biomedical Microdevices, vol. 11, no. 2, pp. 389–400, 2009. View at: Publisher Site | Google Scholar
  206. A. Tijore, S. A. Irvine, U. Sarig, P. Mhaisalkar, V. Baisane, and S. Venkatraman, “Contact guidance for cardiac tissue engineering using 3D bioprinted gelatin patterned hydrogel,” Biofabrication, vol. 10, no. 2, article 025003, 2018. View at: Publisher Site | Google Scholar
  207. B. Xu, A. Magli, Y. Anugrah, S. J. Koester, R. C. R. Perlingeiro, and W. Shen, “Nanotopography-responsive myotube alignment and orientation as a sensitive phenotypic biomarker for Duchenne muscular dystrophy,” Biomaterials, vol. 183, pp. 54–66, 2018. View at: Publisher Site | Google Scholar
  208. G. Abagnale, A. Sechi, M. Steger et al., “Surface topography guides morphology and spatial patterning of induced pluripotent stem cell colonies,” Stem Cell Reports, vol. 9, no. 2, pp. 654–666, 2017. View at: Publisher Site | Google Scholar
  209. Y. Chen, L. Ju, M. Rushdi, C. Ge, and C. Zhu, “Receptor-mediated cell mechanosensing,” Molecular Biology of the Cell, vol. 28, no. 23, pp. 3134–3155, 2017. View at: Publisher Site | Google Scholar
  210. J. Wang, A. Chen, D. K. Lieu et al., “Effect of engineered anisotropy on the susceptibility of human pluripotent stem cell-derived ventricular cardiomyocytes to arrhythmias,” Biomaterials, vol. 34, no. 35, pp. 8878–8886, 2013. View at: Publisher Site | Google Scholar
  211. C. Xu, L. Wang, Y. Yu et al., “Bioinspired onion epithelium-like structure promotes the maturation of cardiomyocytes derived from human pluripotent stem cells,” Biomaterials Science, vol. 5, no. 9, pp. 1810–1819, 2017. View at: Publisher Site | Google Scholar
  212. G. K. Xu, X. Q. Feng, and H. Gao, “Orientations of cells on compliant substrates under biaxial stretches: a theoretical study,” Biophysical Journal, vol. 114, no. 3, pp. 701–710, 2018. View at: Publisher Site | Google Scholar
  213. Y. Tan, D. Richards, R. Xu et al., “Silicon nanowire-induced maturation of cardiomyocytes derived from human induced pluripotent stem cells,” Nano Letters, vol. 15, no. 5, pp. 2765–2772, 2015. View at: Publisher Site | Google Scholar
  214. D. J. Richards, Y. Tan, R. Coyle et al., “Nanowires and electrical stimulation synergistically improve functions of hiPSC cardiac spheroids,” Nano Letters, vol. 16, no. 7, pp. 4670–4678, 2016. View at: Publisher Site | Google Scholar
  215. E. Huethorst, M. Hortigon, V. Zamora-Rodriguez et al., “Enhanced human-induced pluripotent stem cell derived cardiomyocyte maturation using a dual microgradient substrate,” ACS Biomaterials Science & Engineering, vol. 2, no. 12, pp. 2231–2239, 2016. View at: Publisher Site | Google Scholar
  216. K. A. Kilian, B. Bugarija, B. T. Lahn, and M. Mrksich, “Geometric cues for directing the differentiation of mesenchymal stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 11, pp. 4872–4877, 2010. View at: Publisher Site | Google Scholar
  217. F. F. B. Hulshof, Y. Zhao, A. Vasilevich et al., “NanoTopoChip: high-throughput nanotopographical cell instruction,” Acta Biomaterialia, vol. 62, pp. 188–198, 2017. View at: Publisher Site | Google Scholar
  218. F. B. Myers, J. S. Silver, Y. Zhuge et al., “Robust pluripotent stem cell expansion and cardiomyocyte differentiation via geometric patterning,” Integrative Biology, vol. 5, no. 12, pp. 1495–1506, 2013. View at: Publisher Site | Google Scholar
  219. F. Karimi, A. J. O'Connor, G. G. Qiao, and D. E. Heath, “Integrin clustering matters: a review of biomaterials functionalized with multivalent integrin-binding ligands to improve cell adhesion, migration, differentiation, angiogenesis, and biomedical device integration,” Advanced Healthcare Materials, vol. 7, no. 12, article e1701324, 2018. View at: Publisher Site | Google Scholar
  220. D. J. Irvine, A. M. Mayes, and L. G. Griffith, “Nanoscale clustering of RGD peptides at surfaces using comb polymers. 1. Synthesis and characterization of Comb thin films,” Biomacromolecules, vol. 2, no. 1, pp. 85–94, 2001. View at: Publisher Site | Google Scholar
  221. D. J. Irvine, A. V. G. Ruzette, A. M. Mayes, and L. G. Griffith, “Nanoscale clustering of RGD peptides at surfaces using comb polymers. 2. Surface segregation of comb polymers in polylactide,” Biomacromolecules, vol. 2, no. 2, pp. 545–556, 2001. View at: Publisher Site | Google Scholar
  222. E. Altrock, C. A. Muth, G. Klein, J. P. Spatz, and C. Lee-Thedieck, “The significance of integrin ligand nanopatterning on lipid raft clustering in hematopoietic stem cells,” Biomaterials, vol. 33, no. 11, pp. 3107–3118, 2012. View at: Publisher Site | Google Scholar
  223. M. Schvartzman, M. Palma, J. Sable et al., “Nanolithographic control of the spatial organization of cellular adhesion receptors at the single-molecule level,” Nano Letters, vol. 11, no. 3, pp. 1306–1312, 2011. View at: Publisher Site | Google Scholar
  224. V. Schaufler, H. Czichos-Medda, V. Hirschfeld-Warnecken et al., “Selective binding and lateral clustering of α5β1 and αvβ3 integrins: unraveling the spatial requirements for cell spreading and focal adhesion assembly,” Cell Adhesion & Migration, vol. 10, no. 5, pp. 505–515, 2016. View at: Publisher Site | Google Scholar
  225. P. L. Benitez, S. Mascharak, A. C. Proctor, and S. C. Heilshorn, “Use of protein-engineered fabrics to identify design rules for integrin ligand clustering in biomaterials,” Integrative Biology, vol. 8, no. 1, pp. 50–61, 2016. View at: Publisher Site | Google Scholar
  226. S. R. Coyer, A. Singh, D. W. Dumbauld et al., “Nanopatterning reveals an ECM area threshold for focal adhesion assembly and force transmission that is regulated by integrin activation and cytoskeleton tension,” Journal of Cell Science, vol. 125, no. 21, pp. 5110–5123, 2012. View at: Publisher Site | Google Scholar
  227. L. Ye, X. Ni, Z. A. Zhao, W. Lei, and S. Hu, “The application of induced pluripotent stem cells in cardiac disease modeling and drug testing,” Journal of Cardiovascular Translational Research, vol. 11, no. 5, pp. 366–374, 2018. View at: Publisher Site | Google Scholar
  228. A. J. Engler, S. Sen, H. L. Sweeney, and D. E. Discher, “Matrix elasticity directs stem cell lineage specification,” Cell, vol. 126, no. 4, pp. 677–689, 2006. View at: Publisher Site | Google Scholar
  229. G. Pennarossa, R. Santoro, E. F. M. Manzoni, M. Pesce, F. Gandolfi, and T. A. L. Brevini, “Epigenetic erasing and pancreatic differentiation of dermal fibroblasts into insulin-producing cells are boosted by the use of low-stiffness substrate,” Stem Cell Reviews, vol. 14, no. 3, pp. 398–411, 2018. View at: Publisher Site | Google Scholar
  230. A. Arshi, Y. Nakashima, H. Nakano et al., “Rigid microenvironments promote cardiac differentiation of mouse and human embryonic stem cells,” Science and Technology of Advanced Materials, vol. 14, no. 2, article 025003, 2013. View at: Publisher Site | Google Scholar
  231. S. Acevedo-Acevedo and W. C. Crone, “Substrate stiffness effect and chromosome missegregation in hIPS cells,” Journal of Negative Results in Biomedicine, vol. 14, no. 1, p. 22, 2015. View at: Publisher Site | Google Scholar
  232. I. G. Kim, C. H. Gil, J. Seo et al., “Mechanotransduction of human pluripotent stem cells cultivated on tunable cell-derived extracellular matrix,” Biomaterials, vol. 150, pp. 100–111, 2018. View at: Publisher Site | Google Scholar
  233. Y. Zhu, X. Li, R. R. R. Janairo et al., “Matrix stiffness modulates the differentiation of neural crest stem cells in vivo,” Journal of Cellular Physiology, vol. 234, no. 5, pp. 7569–7578, 2019. View at: Publisher Site | Google Scholar
  234. A. J. Engler, C. Carag-Krieger, C. P. Johnson et al., “Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating,” Journal of Cell Science, vol. 121, no. 22, pp. 3794–3802, 2008. View at: Publisher Site | Google Scholar
  235. S. Lee, V. Serpooshan, X. Tong et al., “Contractile force generation by 3D hiPSC-derived cardiac tissues is enhanced by rapid establishment of cellular interconnection in matrix with muscle-mimicking stiffness,” Biomaterials, vol. 131, pp. 111–120, 2017. View at: Publisher Site | Google Scholar
  236. L. Macri-Pellizzeri, E. M. De-Juan-Pardo, F. Prosper, and B. Pelacho, “Role of substrate biomechanics in controlling (stem) cell fate: implications in regenerative medicine,” Journal of Tissue Engineering and Regenerative Medicine, vol. 12, no. 4, pp. 1012–1019, 2018. View at: Publisher Site | Google Scholar
  237. M. Wheelwright, Z. Win, J. L. Mikkila, K. Y. Amen, P. W. Alford, and J. M. Metzger, “Investigation of human iPSC-derived cardiac myocyte functional maturation by single cell traction force microscopy,” PLoS One, vol. 13, no. 4, article e0194909, 2018. View at: Publisher Site | Google Scholar
  238. A. J. S. Ribeiro, Y. S. Ang, J. D. Fu et al., “Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 41, pp. 12705–12710, 2015. View at: Publisher Site | Google Scholar
  239. D. W. Zhou, T. T. Lee, S. Weng, J. Fu, and A. J. García, “Effects of substrate stiffness and actomyosin contractility on coupling between force transmission and vinculin-paxillin recruitment at single focal adhesions,” Molecular Biology of the Cell, vol. 28, no. 14, pp. 1901–1911, 2017. View at: Publisher Site | Google Scholar
  240. X. Yang, L. Pabon, and C. E. Murry, “Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes,” Circulation Research, vol. 114, no. 3, pp. 511–523, 2014. View at: Publisher Site | Google Scholar
  241. M. Jafarkhani, Z. Salehi, R. Kowsari-Esfahan et al., “Strategies for directing cells into building functional hearts and parts,” Biomaterials Science, vol. 6, no. 7, pp. 1664–1690, 2018. View at: Publisher Site | Google Scholar
  242. H. Yu, Y. S. Lui, S. Xiong et al., “Insights into the role of focal adhesion modulation in myogenic differentiation of human mesenchymal stem cells,” Stem Cells and Development, vol. 22, no. 1, pp. 136–147, 2013. View at: Publisher Site | Google Scholar
  243. J. Du, X. Chen, X. Liang et al., “Integrin activation and internalization on soft ECM as a mechanism of induction of stem cell differentiation by ECM elasticity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 23, pp. 9466–9471, 2011. View at: Publisher Site | Google Scholar
  244. D. Missirlis and J. P. Spatz, “Combined effects of PEG hydrogel elasticity and cell-adhesive coating on fibroblast adhesion and persistent migration,” Biomacromolecules, vol. 15, no. 1, pp. 195–205, 2014. View at: Publisher Site | Google Scholar
  245. Z. Wu, S. V. Plotnikov, A. Y. Moalim, C. M. Waterman, and J. Liu, “Two distinct actin networks mediate traction oscillations to confer focal adhesion mechanosensing,” Biophysical Journal, vol. 112, no. 4, pp. 780–794, 2017. View at: Publisher Site | Google Scholar
  246. W. W. Sharp, D. G. Simpson, T. K. Borg, A. M. Samarel, and L. Terracio, “Mechanical forces regulate focal adhesion and costamere assembly in cardiac myocytes,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 273, no. 2, pp. H546–H556, 1997. View at: Publisher Site | Google Scholar
  247. S. Hirth, A. Bühler, J. B. Bührdel et al., “Paxillin and focal adhesion kinase (FAK) regulate cardiac contractility in the zebrafish heart,” PLoS One, vol. 11, no. 3, article e0150323, 2016. View at: Publisher Site | Google Scholar
  248. P. M. Tan, K. S. Buchholz, J. H. Omens, A. D. McCulloch, and J. J. Saucerman, “Predictive model identifies key network regulators of cardiomyocyte mechano-signaling,” PLoS Computational Biology, vol. 13, no. 11, article e1005854, 2017. View at: Publisher Site | Google Scholar
  249. Y. W. Chun, D. E. Voyles, R. Rath et al., “Differential responses of induced pluripotent stem cell-derived cardiomyocytes to anisotropic strain depends on disease status,” Journal of Biomechanics, vol. 48, no. 14, pp. 3890–3896, 2015. View at: Publisher Site | Google Scholar
  250. K. Kroll, M. Chabria, K. Wang, F. Häusermann, F. Schuler, and L. Polonchuk, “Electro-mechanical conditioning of human iPSC-derived cardiomyocytes for translational research,” Progress in Biophysics and Molecular Biology, vol. 130, Part B, pp. 212–222, 2017. View at: Publisher Site | Google Scholar
  251. O. J. Abilez, E. Tzatzalos, H. Yang et al., “Passive stretch induces structural and functional maturation of engineered heart muscle as predicted by computational modeling,” Stem Cells, vol. 36, no. 2, pp. 265–277, 2018. View at: Publisher Site | Google Scholar
  252. L. F. Kadem, K. G. Suana, M. Holz et al., “High-frequency mechanostimulation of cell adhesion,” Angewandte Chemie, vol. 56, no. 1, pp. 225–229, 2017. View at: Publisher Site | Google Scholar
  253. S. Roy and M. K. Mathew, “Fluid flow modulates electrical activity in cardiac hERG potassium channels,” The Journal of Biological Chemistry, vol. 293, no. 12, pp. 4289–4303, 2018. View at: Publisher Site | Google Scholar
  254. J. L. Ruan, N. L. Tulloch, M. V. Razumova et al., “Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue,” Circulation, vol. 134, no. 20, pp. 1557–1567, 2016. View at: Publisher Site | Google Scholar
  255. C. M. Borza, Y. Su, X. Chen et al., “Inhibition of integrin α2β1 ameliorates glomerular injury,” Journal of the American Society of Nephrology, vol. 23, no. 6, pp. 1027–1038, 2012. View at: Publisher Site | Google Scholar
  256. C. A. Lowell and T. N. Mayadas, “Overview: studying integrins in vivo,” in Integrin and Cell Adhesion Molecules. Methods in Molecular Biology (Methods and Protocols), vol 757, M. Shimaoka, Ed., pp. 369–397, Humana Press, Totowa, NJ, USA, 2012. View at: Publisher Site | Google Scholar
  257. E. Cimetta and G. Vunjak-Novakovic, “Microscale technologies for regulating human stem cell differentiation,” Experimental Biology and Medicine, vol. 239, no. 9, pp. 1255–1263, 2014. View at: Publisher Site | Google Scholar

Copyright © 2019 Rosaria Santoro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1990 Views | 625 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.